Top

Chaan S. Ng, MBBS, MD, PhD

Department of Abdominal Imaging, Division of Diagnostic Imaging

About Dr. Chaan S. Ng

Dr. Ng is Professor of Radiology at The University of Texas MD Anderson Cancer Center. He obtained his medical degree from University of London, London, United Kingdom. He is a radiologist specializing in body imaging (Abdomen and Pelvis), with extensive experience in CT, MRI and PET.

Primary Appointment

Professor, Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Diagnostic & Interventional Imaging, The University of Texas School of Health at Houston, Houston, TX

Dual/Joint/Adjunct Appointment

Adjunct Faculty, Department of Radiology, Christian Medical College, Vellore, Tamil Nadu

Professor, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Diagnostic & Interventional Imaging, The University of Texas School of Health at Houston, Houston, TX

Research Interests

Body CT, MRI, and PET-CT

Clinical Interests

Body Imaging - CT, MRI, PET-CT

Education & Training

Degree-Granting Education

2022	University of Cambridge, Cambridge, GB, Medicine, MD (Higher Research degree)
2015	University of Cambridge, Cambridge, GB, Medicine, Ph.D
1995	Royal College of Radiologists, London, GB, Diagnostic Radiology, FRCR
1993	Christ's College, University of Cambridge, Cambridge, GB, Chemical Engineering, MEng
1992	Royal College of Physicians, London, GB, Internal Medicine, MRCP
1989	Royal Free Hospital School of Medicine, University of London, London, GB, Medicine, MBBS
1983	Christ's College, University of Cambridge, Cambridge, GB, Chemical Engineering, MA
1979	Christ's College, University of Cambridge, Cambridge, GB, Engineering, BA

Postgraduate Training

1997-1998	Clinical Fellowship, Body Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
1994-1997	Clinical Residency, Senior Registrar in Diagnostic Radiology, St. George's Hospital Rotational Training Scheme, London
1992-1994	Clinical Residency, Registrar in Diagnostic Radiology, King's College Hospital, London
1992-1992	Clinical Residency, Senior House Officer in Neurology, The Radcliffe Infirmary, Oxford
1991-1992	Clinical Residency, Senior House Officer in Thoracic Medicine, The London Chest Hospital, London
1991-1991	Clinical Residency, Rotating Senior House Officer on Post-graduate Training Scheme in Medicine: Geriatric Medicine, The Whittington Hospital, London
1991-1991	Clinical Residency, Rotating Senior House Officer on Post-graduate Training Scheme in Medicine: Accident and Emergency, The Whittington Hospital, London
1990-1991	Clinical Residency, Rotating Senior House Officer on Post-graduate Training Scheme in Medicine: Clinical Oncology, Gastroenterology and General Medicine, The Whittington Hospital, London
1990-1990	Clinical Internship, General and Thoracic Surgery and Urology, Basildon Hospital, Essex
1989-1990	Clinical Internship, General Medicine, Endocrinology and Diabetes, Royal Free Hospital, London

Licenses & Certifications

2004	Texas Medical Board License
2002	American Board of Radiology
1995	Fellow of the Royal College of Radiologists
1992	Member of Royal College of Physicians
1989	General Medical Council

Experience & Service

Faculty Academic Appointments

Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2019

Associate Professor, Department of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, 2010 - 2016

Assistant Professor, Department of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, 2008 - 2010

Associate Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2011

Assistant Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2006

College Teaching Fellow, Wolf Fellow, and Supervisor, Christ's College, Cambridge, 1999 - 2001

University Lecturer (Assistant Professor Equivalent), School of Clinical Medicine, University of Cambridge, Cambridge, 1998 - 2001

Administrative Appointments/Responsibilities

Director of Studies in Anatomy, Christ's College, Cambridge, 1999 - 2001

Other Professional Positions

Consultant, General Electric Healthcare, USA, 2016 - Present

Representative, Gynecologic Cancer Intergroup, Tokyo, 2015

Representative, 5th Ovarian Cancer Consensus Conference, Tokyo, 2015

Member, American College of Radiology Imaging Network Gynecologic Committee, Philadelphia, PA, 2010 - 2015

Consultant, Novartis Pharmaceuticals Corp, USA, 2010

Committee Representative, American College of Radiology Imaging Accrual Working Group, Philadelphia, PA, 2010 - Present

Member, American College of Radiology Imaging Network, Philadelphia, PA, 2009 - Present

Representative, Global Academic Programs Initiative, The University of Texas MD Anderson Cancer Center, Guangzhou, 2008

Consultant, MGI Pharma, USA, 2003 - 2004

Member, Governing Body, Christ's College, Cambridge, 1999 - 2001

Member, Interviewing Committee of Medical Students, Cambridge University, Cambridge, 1999 - 2001

Honorary Consultant (Attending Physician with Staff Privileges Equivalent), Addenbrooke's Hospital, Cambridge, 1998 - 2001

Intramural Institutional Committee Activities

Member, PRS Retirement Board, The University of Texas MD Anderson Cancer Center, 2025 - Present

Extramural Institutional Committee Activities

Member, PRS Budget and Finance Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2025

Member, PRS Retirement Board, The University of Texas MD Anderson Cancer Center, 2019 - 2023

Member, Abdominal Imaging Leadership Council, The University of Texas MD Anderson Cancer Center, 2018 - 2019

Vice Chair, Diagnostic Radiology Awards Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2019

Member, PRS Faculty Clinical Revenue Cycle Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2017

Member, PRS Leadership & Institutional Service Award, The University of Texas MD Anderson Cancer Center, 2012 - 2014

Member, Travel Advisory Committee, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2010 - 2012

Member, PRS Faculty Compensation and Benefits Advisory Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2015

Member, Department of Diagnostic Radiology Body Imaging Quality Improvement Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2010

Member, Division of Diagnostic Imaging Quality Improvement Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2011

Member, Hepatocellular Carcinoma Interdisciplinary Research Group, The University of Texas MD Anderson Cancer Center, 2009 - 2011

Member, The Institute for Personalized Cancer Therapy Working Group, The University of Texas MD Anderson Cancer Center, 2008 - 2013

Member, U01 Steering Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2009

Member, Abdominal Chief Search Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2008

Member, Scientific Publications Advisory Board, The University of Texas MD Anderson Cancer Center, 2006 - Present

Member, Clinical Research Committee, The University of Texas MD Anderson Cancer Center, 2004 - 2006

Member, Screening Committee of Fellowship Candidates, The University of Texas MD Anderson Cancer Center, 2002 - 2004

Editorial Activities

Editor/Service on Editorial Board(s), World Journal of Gastrointestinal Surgery, 2009 - Present

Honors & Awards

2018	Best Oral Presentation, "Renal events following intravenous iodinated contrast media administration among inpatients admitted with cancer", International Cancer Imaging Society
2015	Outstanding Research Award 2015, The University of Texas M.D. Anderson Cancer Center
2012	Best Poster Award, "Measuring Response to Targeted Therapies in Metastatic Renal Cell Carcinoma: Current Concepts & Future Directions", Society of Uroradiology
2010	Shipley Award for Best Abstract Presented, "Results of adopting posterior retroperitoneoscopic adrenalectomy into surgical care", Southern Surgical Association
2008	Robert and Elma Kemp Harper Prize for Best Paper in Gastrointestinal Radiology in Clinical Radiology, "Minimal-preparation abdominopelvic CT in frail and elderly patients: prognostic value of colonic and extracolonic findings", Royal College of Radiologists
2007	Cum Laude Educational Exhibition, "Papillary renal cell carcinoma: radiologic pathologic correlation and spectrum of disease", Radiological Society of North America
2004	Certificate of Merit Electronic Exhibit, "The spectrum of manifestations of metastatic malignant melanoma", European Congress of Radiology
2003	Certificate of Merit Poster Presentation, "Imaging approach to resectability evaluation of suprapancreatic and hilar cholangiocarcinoma", Radiological Society of North America
2003	First Place, "Sonography of the eye: normal anatomy and pathology", Federation for Ultrasound in Medicine and Biology, American Institute of Ultrasound in Medicine
2002	Certificate of Merit Poster Presentation, "What are those nodes called? A pictorial review of the abdominal nodal stations", Radiological Society of North America
2002	Best Scientific Paper and Prize Oral Presentation, "A prospective randomised study of early abdominopelvic computed tomography (CT) in the management of patients with acute abdominal pain of indeterminate aetiology", European Congress of Radiology
2002	Certificate of Merit Poster Presentation, "Sonography of the eye: normal anatomy and pathology", Radiological Society of North America
2002	Robert and Elma Kemp Harper Prize for Best Paper in Gastrointestinal Radiology in Clinical Radiology, "Caecal carcinomas in the elderly: serosal margin blurring and terminal ileal wall thickening, useful signs in minimal preparation CT", Royal College of Radiologist
1999	Certificate of Merit Poster Presentation, "Malignant pleural mesothelioma: the spectrum of manifestations on CT in 70 cases", American Roentgen Ray Society
1999	Cum Laude Poster Presentation, "MR Imaging of tumors involving the perineum: imaging anatomy, diagnosis and staging, treatment evaluation, and surgical correlation", European Congress of Radiology
1998	Certificate of Merit Poster Presentation, "MR Imaging of tumors involving the perineum: imaging anatomy, diagnosis and staging, treatment evaluation, and surgical correlation", American Roentgen Ray Society
1997	Highly Commended Poster Presentation, "Correlation of CT with histo-pathological findings in patients with gastric and oesophageal carcinomas following neo-adjuvant chemotherapy", Radiology 1997
1989	Distinction Viva in Pathology, University of London
1989	Esther Francis White Memorial Prize for Distinction in Final M.B.B.S, Royal Free Hospital School of Medicine, University of London
1989	Certificate of Merit in Medicine, Royal Free Hospital School of Medicine, University of London
1989	Certificate of Merit in Pathology, Royal Free Hospital School of Medicine, University of London
1989	Certificate of Merit in Surgery, Royal Free Hospital School of Medicine, University of London
1989	Certificate of Merit in General Practice, Royal Free Hospital School of Medicine, University of London
1989	Distinction Viva in Medicine, University of London
1989	Distinction in Clinical Pharmacology and Therapeutics in Final M.B.B.S, University of London
1989	ICI Pharmaceuticals Prize in Clinical Pharmacology and Therapeutics, Royal Free Hospital School of Medicine, University of London
1988	Certificate of Merit in Tropical Medicine, Royal Free Hospital School of Medicine, University of London
1988	First Prize in Medical Defence Union Elective Bursary Competition, Medical Defence Union
1988	Isabel Thorne Elective Bursary, Royal Free Hospital School of Medicine, University of London
1987	Sarah Holborn Clinical Bursary, Royal Free Hospital School of Medicine, University of London
1986	Alfred Langton Clinical Scholarship, Royal Free Hospital School of Medicine, University of London
1986	Certificate of Merit in Psychology, Royal Free Hospital School of Medicine, University of London
1986	George Smith Prize in Second Year Subjects, Royal Free Hospital School of Medicine, University of London
1985 - 1986	Certificate of Merit in Physiology, Royal Free Hospital School of Medicine, University of London
1985	Annie Brooks Prize in Biochemistry, Royal Free Hospital School of Medicine, University of London
1985	Certificate of Merit in Anatomy, Royal Free Hospital School of Medicine, University of London
1985	Isabel Thorne Prize in Cell Structure and Function, Royal Free Hospital School of Medicine, University of London
1985	Mabel Sharman-Crawford Scholarship, Royal Free Hospital School of Medicine, University of London
1985	Mary Lucas Keene Prize for Highest Marks in First Year Subjects, Royal Free Hospital School of Medicine, University of London
1985	Mary Waller Prize in Medical Physics, Royal Free Hospital School of Medicine, University of London
1985	William Marsden Scholarship and Medal, Royal Free Hospital School of Medicine, University of London
1984 - 1988	Edmund and Alan Lewis Scholarship, Royal Free Hospital School of Medicine, University of London
1984 - 1985	Mary Scholfield Scholarship, Royal Free Hospital School of Medicine, University of London
1980	Christ's College B.A. Scholarship, Christ's College, University of Cambridge
1980	Christ's College Prize for First Class in Part II of Tripos Examinations, Christ's College, University of Cambridge
1979	Christ's College Prize for First Class in Part I of Tripos Examinations, Christ's College, University of Cambridge
1979	Christ's College Scholarship, Christ's College, University of Cambridge

Professional Memberships

Society of Abdominal Radiology

2012 - Present

Society of Urological Radiology

2010 - 2012

Texas Medical Association

2004 - Present

American Society of Clinical Oncology

2004 - Present

Harris County Medical Society

2004 - Present

Houston Radiological Society

2004 - Present

European Society of Gastrointestinal and Abdominal Radiology

2003 - 2012

International Cancer Imaging Society

2001 - Present

American Roentgen Ray Society

1999 - Present

European Congress of Radiology

1996 - Present

Royal College of Radiologists

1995 - Present

Selected Presentations & Talks

Local Presentations

2025. Radiology for dietitians. Invited. Continuing Education for Dietitians. Houston, Texas, US.
2016. General principles in cross-sectional imaging in CT and MRI in chest, abdomen/pelvis: anatomy, techniques and approaches. Invited. Imaging and Response Evaluation in Clinical Trials. Houston, TX, US.
2014. General principles CT chest. Invited. Imaging and Response Evaluation in Clinical Trials Conference. Houston, TX, US.
2014. General principles: CT abdomen/pelvis - anatomy, techniques and approaches. Invited. Imaging and Response Evaluation in Clinical Trials Conference. Houston, TX, US.
2014. CT Shuttle. Invited. Investigational Cancer Therapeutics Grand Rounds. Houston, Texas, US.
2013. Response evaluation of solid tumors - RECIST criteria. Conference. Imaging and Response Evaluation in Clinical Trials. Houston, TX, US.
2013. Hereditary endocrine neoplasia case conference. Invited. Hereditary endocrine neoplasia case conference. Houston, TX, US.
2012. General principles: CT abdomen/pelvis - anatomy, techniques and approaches. Invited. Imaging and Response Evaluation In Clinical Trials. Houston, TX, US.
2012. Computed tomography perfusion: what is it and how can we use it?. Invited. Clinical Trials Faculty meeting. Houston, Texas, US.
2011. Genitourinary Imaging, Anatomy, Physiology and Oncology for Medical Physicists. Invited. Clinical Imaging. Houston, Texas, US.
2011. General principles: CT abdomen/pelvis - anatomy, techniques and approaches. Invited. Imaging and Response Evaluation in Clinical Trials. Houston, TX, US.
2011. General principles: CT chest - anatomy, techniques and approaches. Invited. Imaging and Response Evaluation in Clinical Trials. Houston, TX, US.
2011. General principles: PET/CT and PERCIST. Invited. Imaging and Response Evaluation in Clinical Trials. Houston, TX, US.
2010. Genitourinary Imaging, Anatomy, Physiology and Oncology for Medical Physicists. Invited. Clinical Imaging. Houston, TX, US.
2010. Perfusion studies. Invited. Clinical Trials Faculty meeting. Houston, Texas, US.
2010. Objective evaluation of DCE-CT and DCE-MRI in assessing tumor perfusion and permeability changes with AZ drugs in the angiogenesis biological effect area in an animal model. Invited. AstraZeneca and The University of Texas MD Anderson Cancer Center Alliance Collaboration Meeting. Houston, TX, US.
2008. Computed Tomography Urography, continuing education lecture for Imaging Technologists. Invited. Continuing Education for Imaging Technologists. Houston, Texas, US.
2008. Role of radiologist in Urothelial Cancer. Invited. Urothelial carcinoma series, bladder-upper tract cancer didactic module. Houston, Texas, US.
2008. Basics of Computed Tomography chest. Invited. Physician Assistant continuing education. Houston, Texas, US.
2006. Radiology interactions with Phase I. Invited. External Advisory Board, Phase I group. Houston, Texas, US.
2006. Magnetic resonance imaging. Invited. Melanoma Group rounds. Houston, Texas, US.
2006. Results of a study investigating the reproducibility of Dynamic Contrast Enhanced Magnetic Resonance Imaging and Computed Tomography, Phase 1 group. Invited. Clinical Trials Faculty meeting. Houston, Texas, US.
2005. Tumor measurements. Invited. Melanoma Group rounds. Houston, Texas, US.
2005. Intravenous infiltrations, Radiology Nurses. Invited. Continuing Education for Nurses. Houston, Texas, US.
2004. Radiology dictations and transcriptions, Radiology Transcriptionists. Invited. Houston, Texas, US.
2004. Functional imaging. Invited. Clinical Trials Faculty meeting. Houston, Texas, US.
2004. Potential for collaborative studies in dynamic contrast enhanced Magnetic Resonance Imaging & Computed Tomography, Phase I working group. Invited. Clinical Trials Faculty meeting. Houston, Texas, US.
2004. Functional computed tomography. Invited. Institutional Grand Rounds. Houston, TX, US.

Regional Presentations

2008. Perfusion CT in oncology. Invited. GE Healthcare. Milwaukee, WI, US.
2004. Clinical trials endpoints for the most rapid assessment of efficacy of new therapeutics for patients with pancreatic cancer. Invited. Bartella Foundation Think Tank on Pancreatic Cancer. Phoenix, AZ, US.
2004. The best new therapeutic agent there is to evaluate against pancreatic cancer. Invited. Bartella Foundation Think Tank on Pancreatic Cancer. Phoenix, AZ, US.
2001. Cancer networks. Conference. East Anglican Radiological Society Meeting. Cambridge, GB.
1999. Pancreatic computed tomography. Invited. East Anglican Radiological Society Meeting. Cambridge, GB.

National Presentations

2023. A Phase 1 Dose Escalation Study of Temsirolimus in Combination with Metformin in Patients with Advanced Endometrial Cancers [Poster Presentation]. Poster. Boston, MA, US.
2014. ACRIN6696-GOGO262 Perfusion CT in ovarian cancer. Invited. American College of Radiology Imaging Network (ACRIN) Fall Group Meeting. Orlando, FL, US.
2014. ACRIN6696-GOGO262 Perfusion Computed Tomography in ovarian cancer. Invited. Eastern Cooperative Oncology Group (ECOG-American College of Radiology Imaging Network (ACRIN) Fall Group Meeting. Orlando, FL, US.
2012. ACRIN 6695/GOG 0262 Update and Questions. Invited. American College of Radiology Imaging Network (ACRIN) Gynecologic Committee. Hollywood, FL, US.
2011. ACRIN 6695/GOG 0262 update and questions. Invited. American College of Radiology Imaging Network (ACRIN) Fall Group Meeting. Arlington, VA, US.
2011. ACRIN 6695/GOG 0262 update and questions. Invited. American College of Radiology Imaging Network (ACRIN) Fall Group Meeting. Arlington, VA, US.
2010. ACRIN 6695-GOG0262: Perfusion imaging as a cancer biomarker. Invited. American College of Radiology Imaging Network (ACRIN) Fall Group Meeting. Arlington, VA, US.
2010. ACRIN 6695-GOG0262: Perfusion imaging as a cancer biomarker. Invited. American College of Radiology Imaging Network (ACRIN) Annual Meeting. Arlington, VA, US.
2009. Determination of central line position in the superior vena cava or azygous vein on frontal chest radiographs [Scientific Exhibit]. 109th Annual Meeting of the American Roentgen Ray Society. Boston, MA, US.
2006. Perfusion CT in oncology. Invited. American College of Radiology Imaging Network (ACRIN) Lung Group. Washington, DC, US.
2004. Diagnostic Imaging of Pancreatic Tumors. Invited. Hepatobiliary Tumor course. Princeville, Kauai, HI, US.
2004. Diagnostic Imaging of Hepatobiliary Tumors. Invited. Hepatobiliary Tumor course. Princeville, Kauai, HI, US.
2002. Multiplanar reformatting and 3-D volume rendering of multidetector, multiphase contrast-enhanced computed tomography for the diagnosis, staging, and surgical planning of renal tumors [Poster Presentation]. Poster. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2002. What are those nodes called? A pictorial review of the abdominal nodal stations [Certificate of Merit Poster Presentation Award]. Poster. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2000. Pancreatic computed tomography. Invited. Symposium Siemens. Newbury, Berkshire, GB.
1999. Pancreatic computed tomography. Invited. Symposium Siemens. Leeds, Yorkshire, GB.
1999. The evolving role of spiral CT in the investigation of the abdomen, progress in gastroenterology. Invited. London, GB.
1996. Radiology for the Membership of the Royal College of Physicians. Invited. Great Ormond Street Hospital. London, GB.
1996. Pediatric chest radiography. Invited. London and Home Counties Branch of the Society of Radiographers Meeting. London, GB.

International Presentations

2025. CT perfusion. Invited. 23rd Asian Oceanian Congress of Radiology (AOCR) & 77th Annual Conference of Indian Radiological and Imaging Association (IRIA). Chennai, IN.
2025. RECIST. Invited. 23rd Asian Oceanian Congress of Radiology (AOCR) & 77th Annual Conference of Indian Radiological and Imaging Association (IRIA). Chennai, IN.
2025. The future. Invited. 23rd Asian Oceanian Congress of Radiology (AOCR) & 77th Annual Conference of Indian Radiological and Imaging Association (IRIA). Chennai, IN.
2023. Detection of Pancreatic Adenocarcinoma in 2022 : DECT or High Resolution MDCT. Conference. Society of Abdominal Radiology. Austin, US.
2023. Beyond the 3 P’s: Adrenal Involvement in MEN1. Conference. 18th International Workshop on Multiple Endocrine Neoplasia and Other Rare Endocrine Tumors 2023. Marseille, FR.
2022. Adrenal involvement in MEN1 [Electronic Poster Presentation]. Conference. International Conference on Surgical Oncology (SSO) and Advanced Cancer Therapies (ACT). Dallas, US.
2022. The future of clinical evidence generation. Invited. European Congress of Radiology (ECR) Annual Meeting. Vienna, AT.
2022. Beyond the 3 P’s: Adrenal Involvement in MEN1 [Poster Presentation]. Poster. Dallas, US.
2022. The Adrenal Incidentaloma: Surveillance and Surgical Approaches. Invited. Southern Society of Clinical Surgeons. Houston, US.
2021. Contrast media and MACE or renal events in high-risk patients undergoing intra-arterial procedures [Oral Presentation]. Conference. Cardiorenal Connections Conference. Dallas, US.
2019. A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eligible for cytoreductive nephrectomy, metastasectomy or post-treatment biopsy (Bx) [Abstract Presentation]. Conference. American Society of Clinical Oncology 55th Annual Meeting. Chicago, US.
2019. Imaging considerations in high risk oncology patients?. Invited. Acute Kidney Injury & Chronic Renal Replacement Therapy (AKI-CRRT) 2019 conference. San Diego, US.
2018. Rates of adrenal pathology in MEN1 [Abstract Presentation]. Conference. Western Surgical Association 126th Scientific Session 2018 Annual Meeting. San Jose Del Cabo, MX.
2018. Considerations when imaging oncological patients. Invited. Symposium at St. Luke Hospital. Manila, PH.
2018. Considerations when imaging oncological patients. Invited. Symposium at National Kidney and Transplant Institute. Manila, PH.
2018. Updates in Oncologic Imaging. Invited. 2018 Joint Annual Convention CT-MRI Society of the Philippines and Ultrasound Society of the Philippines, Plenary Talk. Manila, PH.
2018. Computed tomography perfusion and dose strategy. Invited. Singapore, US.
2018. Vignettes in oncologic imaging. Invited. Singapore, US.
2018. Oncologic computed tomography imaging & its applications. Invited. Bangkok, TH.
2018. Considerations when imaging oncological patients. Invited. Khon Kaen, TH.
2018. Oncologic computed tomography imaging & its applications. Invited. Bangkok, TH.
2018. Renal events following intravenous iodinated contrast media administration among inpatients admitted with cancer [Best Oral Presentation Award]. Conference. Renal events following intravenous iodinated contrast media administration among inpatients admitted with cancer [Best Oral Presentation Award]. Menton, FR.
2018. Updates in oncologic imaging. Invited. Tianjin, CN.
2018. Updates in oncological imaging. Conference. Updates in oncological imaging. Tianjin, CN.
2018. Opportunities for Imaging and Oncology. Invited. Shenyang, CN.
2018. Workshops and resident training. Invited. Tianjin, CN.
2018. A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eligible for cytoreductive nephrectomy (CN), metastasectomy (MS) or post-treatment biopsy (Bx) [Poster Presentation]. Poster. American Society of Clinical Oncology 54th Annual Meeting. Chicago, US.
2018. Residency training program. Invited. Guangzhou, CN.
2018. Frailty index is a more comprehensive predictor of survival outcomes in patients with small renal masses on active surveillance than conventional parameters [Abstract Presentation]. Conference. American Urological Association 2018 Annual Meeting. San Francisco, US.
2018. Conditional survival and landmark analysis for patients with small renal masses undergoing active surveillance at a tertiary care center [Abstract Presentation]. Conference. American Urological Association Annual Meeting. San Francisco, US.
2018. Opportunities for imaging and oncology. Conference. Opportunities for imaging and oncology. Wuhan, CN.
2018. Bayesian classifiers of solid lesions with dynamic CT: Integrating enhancement density with washout density and delay interval [Oral Presentation]. Conference. Bayesian classifiers of solid lesions with dynamic CT: Integrating enhancement density with washout density and delay interval [Oral Presentation]. Washington, US.
2018. Conditional survival and landmark analysis for patients with small renal masses undergoing active surveillance at a tertiary care center [Abstract Presentation]. Conference. American Society of Clinical Oncology 2018 Genitourinary Cancers Symposium. San Francisco, US.
2017. Computed tomography perfusion for liver cancers. Invited. Singapore, SG.
2017. Vignettes in oncologic imaging. Invited. Singapore, SG.
2017. Conditional survival and landmark analysis for patients with small renal cell carcinoma undergoing active surveillance at a tertiary care center [Poster Presentation]. Poster. 18th Annual Meeting of the Society of Urologic Oncology. Washington, US.
2017. Reproducibility of CT perfusion in ovarian cancer - a substudy of ACRIN 6695/GOG-0262 [Poster Presentation]. Poster. 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, US.
2017. Considerations when imaging oncological patients. Invited. Bangkok, TH.
2017. Considerations when imaging oncological patients. Invited. Chiang Mai, TH.
2017. Imaging optimization for cancer patients’. Invited. 73rd Korean Congress of Radiology and Annual Delegate Meeting of The Korean Society of Radiology (KCR 2017). Seoul.
2017. Fellow of the Royal College of Radiologists/FRANZCR Part 2 viva training and fellowship opportunities. Invited. Gosford, AU.
2017. EphA2 gene targeting using neutral liposomal small interfering RNA (EPHARNA) delivery: A phase I clinical trial [Abstract Presentation]. Conference. 2017 American Society of Clinical Oncology Annual Meeting. Chicago, US.
2017. Classification of adrenal lesions through spatial Bayesian modeling of GLCM [Oral Presentation]. Conference. Classification of adrenal lesions through spatial Bayesian modeling of GLCM [Oral Presentation]. Melbourne, AU.
2017. Clinical activity, immune and molecular correlates of nivolumab vs. nivolumab plus bevacizumab vs nivolumab plus ipilimumab in metastatic renal cell carcinoma [Abstract Presentation]. Conference. Proceedings of the American Association for Cancer Research Annual Meeting 2017. Washington, US.
2017. Radiology training in USA and UK. Invited. Guangzhou, CN.
2017. Contrast-associated acute kidney injury (AKI) in the intensive care unit (ICU): Systematic review and meta-analysis [Oral Presentation]. Conference. Réanimation 2017, Annual Congress of the French Intensive Care Society. Paris, FR.
2016. Medical and specialist training in USA and UK. Invited. Wuhan, CN.
2016. Updates in Oncologic imaging: Structure, Function, Opportunities. Invited. 2016 Central China Oncologic Imaging Forum. Wuhan, CN.
2016. Medical and Specialist training in USA and UK. Radiology reporting and requirements. Invited. Medical and Specialist training in USA and UK. Radiology reporting and requirements. Wuhan, CN.
2016. Medical and specialist training in USA and UK. Radiology reporting and requirements. Invited. The 8th Hubei Academic Conference. Wuhan, CN.
2016. Updates in oncologic imaging: structure, function, opportunities. Invited. Wuhan, CN.
2016. CT imaging does not increase the risk of second malignancy in patients with colorectal liver metastases [Poster Presentation]. Poster. Western Surgical Association 124th Scientific Session 2016 Annual Meeting. Coronado, US.
2016. Effective radiation dose of perfusion CT exams of ovarian cancer patients: a multi-center study [Poster Presentation]. Poster. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, US.
2016. Computed tomography scanning technique and protocols. Invited. Putrajaya, MY.
2016. Magnetic resonance imaging prostate and PIRADS reporting. Invited. Putrajaya, MY.
2016. Magnetic resonance imaging prostate and PIRADS reporting. Invited. Kuching, MY.
2016. Fellow of the Royal College of Radiologists Part 2 tutorial. Invited. Putrajaya, MY.
2016. Adrenal imaging. Invited. 2016 Advanced Course on Surgical Oncology for the America’s Didactic and Practical Hands on Skills Training of Thyroid, Parathyroid, Adrenal and HBP Diseases. Houston, US.
2016. General Principles in Cross-sectional imaging in Computed Tomography and Magnetic Resonance Imaging in chest, abdomen/pelvis: anatomy, techniques and approaches. Invited. Putrajaya, MY.
2016. Radiology resident teaching in USA and UK. Invited. Guangzhou, CN.
2016. Effective radiation dose of perfusion CT exams of ovarian cancer patients: a multi-center study (CID: 2392674) [Oral Presentation]. Conference. Society of Abdominal Radiology 2016 Annual Scientific Meeting and Educational Course. Waikoloa, US.
2016. Cancer Imaging. Invited. Wuhan, CN.
2016. Cancer Imaging. Invited. Guangzhou, CN.
2015. Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced cancers [Abstract Presentation]. Conference. Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced cancers [Abstract Presentation]. Boston, US.
2015. Quality assurance in a multicenter trial evaluating quantitative CT perfusion imaging as a biomarker of patient outcome in ovarian cancer chemotherapy: An ECOG-ACRIN and NRG GOG study [Oral Presentation]. Conference. Radiological Society of North America 101st Scientific Assembly and Annual Meeting. Chicago, US.
2015. CME on body imaging. Invited. Addis Ababa, ET.
2015. Computed tomography and magnetic resonance imaging technique. Invited. Addis Ababa, ET.
2015. A prospective, multi-institutional phase II study of pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumors [Abstract Presentation]. Conference. North American Neuroendocrine Tumor Society 8th Annual Symposium. Austin, US.
2015. Imaging of pancreatic cancer. Invited. Victoria, AU.
2015. Teaching session/case presentation. Invited. Melbourne, AU.
2015. Imaging of pancreatic cancer. Invited. Istanbul, TR.
2015. Imaging of pancreatic cancer. Invited. Istanbul, TR.
2015. CT perfusion as an early biomarker of treatment efficacy in advanced ovarian cancer: An ECOG-ACRIN and NRG GOG study [Poster Presentation]. Poster. 2015 American Society of Clinical Oncology Annual Meeting. Chicago, US.
2015. Feasibility of using virtual unenhanced images to replace true unenhanced images in multiphase renal CT exams [Oral Presentation]. Conference. American Association of Physicists in Medicine (AAPM) Spring Clinical Meeting 2015. St. Louis, US.
2015. Quantitative assessment of motion occurring during shuttle mode computed tomography (CT) acquisitions for body perfusion imaging applications [Poster Presentation]. Conference. Society of Photo-optical Instrumentation Engineers Medical Imaging. Orlando, US.
2014. Quantitative assessment of motion occurring during shuttle mode computed tomography (CT) acquisitions for body perfusion imaging applications [Oral Presentation]. Conference. Radiological Society of North America (RSNA) 100th Scientific Assembly and Annual Meeting. Chicago, US.
2014. Metastatic melanoma: pictorial review of the usual and unusual faces of this serious tumor [Poster Presentation]. Poster. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting. Chicago, US.
2014. IBEX: an open software infrastructure platform to accelerate collaborative work on quantitative image features and predictive models [Oral Presentation]. Conference. American Association of Physicists in Medicine (AAPM) 2014 Innovation 56th Annual Meeting & Exhibition. Austin, US.
2014. Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (The ESPN Trial): a multicenter randomized phase 2 trial [Oral Presentation]. Conference. American Society of Clinical Oncology 50th Annual Meeting. Chicago, US.
2014. Oncologic imaging. Invited. CME for GPs. Taiping, MY.
2014. Oncologic imaging. Invited. Ipoh, MY.
2014. CME, oncologic imaging. Invited. CME, oncologic imaging. Putrajaya, MY.
2014. Challenges and pitfalls: metastatic disease imaging, incidental findings, radiation exposure, research; advanced training program in oncologic imaging. Invited. Challenges and pitfalls: metastatic disease imaging, incidental findings, radiation exposure, research; advanced training program in oncologic imaging. Putrajaya, MY.
2014. PET; advanced training program in oncologic imaging. Invited. PET; advanced training program in oncologic imaging. Putrajaya, MY.
2014. Developments in cancer imaging 2: functional imaging; advanced training program in oncologic imaging. Invited. Developments in cancer imaging 2: functional imaging; advanced training program in oncologic imaging. Putrajaya, MY.
2014. Functional imaging with CT and MRI; advanced training program in oncologic imaging. Invited. Functional imaging with CT and MRI; advanced training program in oncologic imaging. Putrajaya, MY.
2014. Applications of morphologic imaging 1: HCC, rectal, prostate; advanced training program in oncologic imaging. Invited. Applications of morphologic imaging 1: HCC, rectal, prostate; advanced training program in oncologic imaging. Putrajaya, MY.
2014. Tumor response evaluation: RECIST v1.0, v1.1; Advanced Training Program in Oncologic Imaging. Invited. Tumor response evaluation: RECIST v1.0, v1.1; Advanced Training Program in Oncologic Imaging. Putrajaya, MY.
2014. Applications of morphologic imaging 2: screening, CT colonography, CT urography, lung; advanced training program in oncologic imaging. Invited. Applications of morphologic imaging 2: screening, CT colonography, CT urography, lung; advanced training program in oncologic imaging. Putrajaya, MY.
2014. Developments in cancer imaging 1: structure, detection and characterization advanced training program in oncologic imaging. Invited. Developments in cancer imaging 1: structure, detection and characterization advanced training program in oncologic imaging. Putrajaya, MY.
2014. Advanced training program in oncologic imaging. Invited. CME, oncologic imaging. Putrajaya, MY.
2013. ACRIN 6695/GOG-0262 update and questions. Conference. American College of Radiology Imaging Network Gynecologic Committee. Hollywood, US.
2013. Perfusion CT: an early marker in the assessment of tumor response to antiangiogenic drugs [Abstract Presentation]. Conference. 99th Radiological Society of North America Annual Meeting. Chicago, US.
2013. Development of an open-source tool to extract quantitative image features and predict outcome [Abstract Presentation]. Conference. Development of an open-source tool to extract quantitative image features and predict outcome [Abstract Presentation]. Atlanta, US.
2013. Understanding uncertainties in quantitative image features extracted from contrast-enhanced CT images [Poster Presentation]. Poster. American Association of Physicists in Medicine 55th Annual Meeting & Exhibition. Indianapolis, US.
2013. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy [Oral Presentation]. Conference. International Association of Endocrine Surgeons Annual Meeting 2013. Helsinki, FI.
2013. mTOR inhibitor associated noninfectious pneumonitis in patients with metastatic renal cell carcinoma: a single-center experience [Poster Presentation]. Poster. American Society of Clinical Oncology 48th Annual Meeting. Chicago, US.
2013. Updates in oncologic imaging part 1. Invited. Ipoh, MY.
2013. Updates in Oncologic Imaging. Invited. 22nd Annual Scientific Meeting of Singapore Radiological Society & College of Radiologists Singapore: Advances in Oncologic Imaging and Therapy. Singapore, SG.
2013. Computed tomography urography. Invited. 22nd Annual Scientific Meeting of Singapore Radiological Society & College of Radiologists Singapore: Advances in Oncologic Imaging and Therapy. Singapore, SG.
2012. Spectrum of hepatic metastases from neuroendocrine tumors (NET) and pitfalls of the detection and measurements of the lesions [Poster Presentation]. Poster. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, US.
2012. Updates in oncological imaging. Invited. Cefalu, IT.
2012. Everolimus (E) and temsirolimus (T) associated pneumonitis (P) in patients with metastatic renal cell cancer (mRCC): A single-center experience [Poster Presentation]. Poster. American Society of Clinical Oncology (ASCO) 48th Annual Meeting. Chicago, US.
2012. ACRIN 6695 perfusion computed tomography as prognostic imaging biomarker in ovarian cancer [Poster Presentation]. Poster. American Society of Clinical Oncology 48th Annual Meeting. Chicago, US.
2012. Imaging of pancreatic cancer. Invited. Selayang, MY.
2012. Updates on Imaging in Oncology - part 2. Invited. 2012 Joint Scientific Meeting of College of Radiology, AMM (CoR) & Malaysian Society of Radiographers (MSR). Penang, MY.
2012. Updates on Imaging in Oncology - part 1. Invited. 2012 Joint Scientific Meeting of College of Radiology, AMM (CoR) & Malaysian Society of Radiographers (MSR). Penang, MY.
2012. Measuring response to targeted therapies in metastatic renal cell carcinoma: current concepts & future directions [Best Poster Award]. Poster. Abdominal Radiology Course, US.
2012. Fellow of the Royal College of Radiologists / Masters in Radiology tutorial. Invited. Kuala Lumpur, MY.
2012. Challenges in diagnostic imaging in multidisciplinary personalized approach to malignant melanoma. Invited. Prague ONCO 2012. Prague, CZ.
2012. Imaging possibilities in pancreatic cancer. Invited. Prague ONCO 2012. Prague, CZ.
2011. Radiological Findings in RCC. Invited. International renal cancer conference. Houston, US.
2011. Clinical characteristics and outcomes associated with BRAF and NRAS mutations in metastatic melanoma [Abstract Presentation]. Conference. American Society of Clinical Oncology 47th Annual Meeting. Chicago, US.
2011. Imaging of pancreatic cancer. Invited. Serdang, MY.
2011. Imaging of Pancreatic cancer. Invited. Seminar on Oncologic Imaging. Kuala Lumpur, MY.
2011. CT urography. Invited. Seminar on Oncologic Imaging. Kuala Lumpur, MY.
2011. Staging of Renal cancer. Invited. Seminar on Oncologic Imaging. Kuala Lumpur, MY.
2011. Multimodality imaging for metastatic melanoma, seminar on oncologic imaging. Invited. Seminar on Oncologic Imaging. Kuala Lumpur, US.
2011. A blinded study to assess the accuracy of computerized tomography in staging patients with muscle-invasive bladder cancer [Abstract Presentation]. Conference. American Urological Association Annual Meeting 2011. Washington, US.
2011. Fellow of the Royal College of Radiologists tutorials for trainees, seminar on Oncologic Imaging. Invited. Kuala Lumpur, MY.
2011. Imaging of pancreatic cancer. Invited. Melbourne, AU.
2011. Everolimus-associated pneumonitis (EAP) in metastatic renal cell cancer patients: a single-center experience [Poster Presentation]. Poster. Genitourinary Cancers Symposium. Orlando, US.
2011. A randomized phase II study of gemcitabine (G) plus the cardiac glycoside huachansu (H) in the treatment of patients with locally advanced (LAPC) or metastatic pancreatic cancer (MPC) [Poster Presentation]. Poster. Gastrointestinal Cancers Symposium. San Francisco, US.
2010. Results of adopting posterior retroperitoneoscopic adrenalectomy into surgical care [Shipley Award for Best Abstract Presented]. Conference. Southern Surgical Association Annual Meeting. Palm Beach, US.
2010. Survival outcomes of patients who develop new lesions while participating on phase I oncology studies [Abstract Presentation]. Conference. Survival outcomes of patients who develop new lesions while participating on phase I oncology studies [Abstract Presentation]. Santa Fe, US.
2010. Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813 [Oral Presentation]. Conference. World Molecular Imaging Congress. Kyoto, JP.
2010. MRI-guided thermal ablation using multimodality, multifunctional SPIO@Au nanoshell targeted to epidermal growth factor receptors [Poster Presentation]. Poster. World Molecular Imaging Congress. Kyoto, JP.
2010. Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer [Abstract Presentation]. Conference. 14th International Thyroid Congress. Paris, FR.
2010. Long term results in patients (pts) with medullary thyroid cancer (MTC) enrolled in a Phase 1 study of XL184 (BMS 907351), an oral inhibitor of MET, VEGFR2 and RET [Oral Presentation]. Conference. International Thyroid Congress. Paris, FR.
2010. Randomized run-in study of bevacizumab (B) and everolimus (E) in low- to intermediate- grade neuroendocrine tumors (LGNETs) using perfusion CT as functional biomarker [Oral Presentation]. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2010. Long term results in a cohort of medullary thyroid cancer (MTC) patients (pts) in a phase 1 study of XL184 (BMS 907351), an oral inhibitor of MET, VEGFR2 and RET [Oral Presentation]. Conference. Meeting Abstract: 2010 ASCO Annual Meeting. Chicago, US.
2010. A phase I study of bevacizumab in combination with sunitinib, sorafenib, erlotinib plus cetuximab, and trastuzumab plus lapatinib [Oral Presentation]. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2010. A prospective, multi-institutional phase 2 study of GW786034 (pazopanib) and depot octreotide (sandostatin LAR) in advanced low-grade neuroendocrine carcinoma (LGNEC) [Oral Presentation]. Conference. American Society of Clinical Oncology (ASCO) 46th Annual Meeting. Chicago, US.
2010. Sunitinib in papillary renal cell carcinoma (pRCC): results from a single-arm phase II study [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2010. Clear cell renal cell carcinoma: MDCT and MRI appearances [Poster Presentation]. Poster. 110th Annual Meeting of the American Roentgen Ray Society. San Diego, US.
2010. Indications for PET-CT. Invited. Vellore, IN.
2010. Change in tumor size by RECIST correlates linearly with progression-free and overall survival in phase I studies [Poster Presentation]. Poster. American Association for Cancer Research 101st Annual Meeting. Washington, US.
2010. Fellow of the Royal College of Radiologists Part II examination viva tutorial, Part 2 board review. Invited. Vellore, IN.
2010. Clinical outcomes and prognostic factors in 83 patients with pancreatic cancer treated in phase I clinical trials at M. D. Anderson Cancer Center [Poster Presentation]. Conference. American Association for Cancer Research 101st Annual Meeting. Washington, US.
2010. Imaging of pancreatic adenocarcinoma. Invited. Vellore, IN.
2010. CT urography. Invited. Vellore, IN.
2010. Staging of bladder cancer. Invited. International Cancer Imaging Society Satellite Workshop. Kuwait City, KW.
2010. Staging of renal cancer. Invited. International Cancer Imaging Society Satellite Workshop. Kuwait City, KW.
2010. CT urography. Invited. International Cancer Imaging Society Satellite Workshop. Kuwait City, KW.
2010. CT, MR, US and PET for melanoma. Invited. International Cancer Imaging Society Satellite Workshop. Kuwait City, KW.
2010. Active surveillance of an incidental renal mass in the setting of an active or recently treated non-renal malignancy [Poster Presentation]. Conference. American Society of Clinical Oncology Genitourinary Cancers Symposium. San Francisco, US.
2010. Fellow of the Royal College of Radiologists Part II examination viva tutorial, Part 1 board review. Invited. Vellore, IN.
2010. Clear cell renal cell carcinoma: multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) appearances [Poster Presentation]. Poster. Society of Gastrointestinal Radiologists and Society of Uroradiology: Abdominal Radiology Course. Orlando, US.
2009. Active surveillance of an incidental renal mass in the setting of an active or recently treated non-renal malignancy [Poster Presentation]. Conference. The 10th Annual Meeting of the Society of Urologic Oncology in Conjunction with the World Urological Oncology Federation. Bethesda, US.
2009. Secondary displacement of long term central venous catheters into the azygous arch [Oral Presentation]. Conference. 95th Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, US.
2009. The effects of temporal sub-sampling on estimates of CT perfusion parameters in abdominal tissues [Oral Presentation]. Conference. 95th Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, US.
2009. Mechanism for the uptake of long circulating biodegradable polymeric molecular resonance contrast agent in tumor necrotic area [Poster Presentation]. Poster. American Association of Pharmaceutical Scientists Annual Meeting and Exposition. Los Angeles, US.
2009. Preclinical MR imaging of rhesus monkeys with PG-Gd: a novel blood pool contrast imaging agent [Poster Presentation]. Poster. Radiological Society of North America (RSNA) 2009 Scientific Assembly and Annual Meeting. Chicago, US.
2009. Multicenter phase I clinical trial of an insulin like growth factor (IGF-R) inhibitor (IMC-A12) in combination with a mammalian target of rapamycin (mTOR) inhibitor (CCI-779) to overcome resistance to mTOR inhibition [Poster Presentation]. Conference. American Association for Cancer Research-European Organization for Research and Treatment of Cancer-National Cancer Institutes Molecular Targets and Cancer Therapeutics Conference. Boston, US.
2009. Treatment-emergent tumor blood flow changes among patients with advanced low or intermediate grade neuroendocrine carcinoma treated with everolimus and bevacizumab [Oral Presentation]. Conference. Chemotherapy Foundation Symposium XXVII Innovative Cancer Therapy For Tomorrow. New York, US.
2009. Combination trastuzumab, lapatinib, and bevacizumab in HER+ breast cancer and other malignancies [Oral Presentation]. Conference. American Society of Clinical Oncology Breast Cancer Symposium. San Francisco, US.
2009. Imaging of pancreatic cancer. Invited. San Antonio, US.
2009. Pharmacokinetics and MR imaging of rhesus monkeys with PG-Gd, a blood pool imaging agent [Oral Presentation]. Conference. World Molecular Imaging Congress. Montreal, CA.
2009. Mechanism for the uptake of long circulating biodegradable polymeric MR contrast agent in tumor necrotic area [Oral Presentation]. World Molecular Imaging Congress. Montreal, CA.
2009. Preliminary results of a phase 1 study of XL184, a MET, VEGFR2 and RET receptor tyrosine kinase inhibitor (TKI), administered orally to patients with medullary thyroid cancer (TC) [Oral Presentation]. Conference. American Thyroid Association 80th Annual Meeting. Palm Beach, US.
2009. Theranostics of head & neck cancer using targeted hollow gold nanoshells [Oral Presentation]. Conference. World Molecular Imaging Congress. Montreal, CA.
2009. Imaging of pancreatic cancer. Invited. London, GB.
2009. Preliminary results of a phase 1 study of XL184, a MET, VEGFR2 and RET receptor tyrosine kinase inhibitor (TKI), administered orally to patients with Thyroid Cancer (TC) [Oral Presentation]. Conference. World Congress on Thyroid Cancer. Toronto, CA.
2009. Imaging of pancreatic cancer. Invited. London, GB.
2009. The effects of temporal sub-sampling/shifting on estimates of CT perfusion parameters in abdominal tissues [Poster Presentation]. Conference. American Association of Physicists in Medicine 51st Annual Meeting. Anaheim, US.
2009. A phase I trial of liposomal doxorubicin (D), bevacizumab (A), and temsirolimus (T) in advanced malignancy [Abstract Presentation]. Conference. American Society of Clinical Oncology 45th Annual Meeting. Orlando, US.
2009. Hypoxia-inducible factor-1α (HIF-1α) modulation in combination with anti-angiogenic therapy [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. Orlando, US.
2009. A phase I study dose escalation clinical study of hepatic intraarterial cisplatin, combination systemic intravenous liposomal doxorubicin in patients advanced cancer dominant liver involvement [Abstract Presentation]. Conference. American Society of Clinical Oncology 45th Annual Meeting. Orlando, US.
2009. A phase I study of hepatic arterial infusion of Oxaliplatin in combination with systemic Fluorouracil, Leucovorin and Avastin for patients with advanced solid tumors metastatic to the liver [Poster Presentation]. Poster. 100th Annual Meeting of the American Association for Cancer Research. Denver, US.
2009. Reproducibility and cross-validation of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model [Poster Presentation]. Poster. International Society for Magnetic Resonance in Medicine 17th Scientific Meeting and Exhibition. Honolulu, US.
2009. Evaluation of automated versus manual registration techniques for motion correction of lung tumors in helical breath hold CT images [Oral Presentation]. Conference. European Congress of Radiology. Vienna, AT.
2009. Clinical and pathologic characteristics of adenocarcinoid tumors of the appendix: more adeno, less carcinoid [Poster Presentation]. Poster. Clear cell renal cell carcinoma: MDCT and magnetic resonance imaging appearances. Phoenix, US.
2008. Evaluating the effectiveness of MDCT urography in detecting upper tract neoplasms and the implications of urothelial thickening vs filling defects seen on imaging [Oral Presentation]. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, US.
2008. Imaging of renal cancer. Invited. Guangzhou, CN.
2008. Imaging of pancreatic cancer. Invited. Guangzhou, CN.
2008. Imaging of pancreatic cancer. Invited. Shanghai, CN.
2008. Evaluation of automated registration techniques for motion correction of lung tumors in helical breath hold CT images [Oral Presentation]. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, US.
2008. Clinical and pathologic characteristics of adenocarcinoid tumors of the appendix: more adeno, less carcinoid [Poster Presentation]. Conference. 6th International Workshop on Peritoneal Surface Malignancy. Lyon, FR.
2008. Imaging of pancreatic cancer. Invited. 4th Sino-US International Symposium on Gastrointestinal Cancer. Tianjin, CN.
2008. Preliminary results of a phase 1 study of XL184, a MET, VEGFR2 and RET kinase inhibitor, administered orally to patients with medullary thyroid cancer (MTC) [Poster Presentation]. Conference. Symposium on Molecular Targets and Cancer Therapeutic American Association of Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer International Conference. Geneva, CH.
2008. Preliminary results of a phase 1 study of XL184, a MET, VEGFR2 and RET kinase inhibitor, administered orally to patients with medullary thyroid cancer (MTC) [Oral Presentation]. Conference. 79th Annual Meeting of the American Thyroid Association. Chicago, US.
2008. A phase I study of hepatic arterial infusion of oxaliplatin plus intravenous fluorouracil, leucovorin and bevacizumab in patients with predominant hepatic metastases [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2008. A phase 1 study of XL184, a RET, VEGFR2 & MET kinase inhibitor, in patients (pts) with advanced malignancies, including pts with medullary thyroid cancer (MTC) [Oral Presentation]. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2008. A phase I study of imexon in combination with docetaxel (DOC) for the treatment of patients with breast, lung and prostate cancer [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2008. A phase I dose escalation study of E7080, a multikinase inhibitor, in patients with advanced solid tumors [Abstract Presentation]. Conference. American Society of Clinical Oncology 44th Annual Meeting. Chicago, US.
2008. Any rise in creatinine is associated with mortality in critically ill pediatric patients with cancer [Poster Presentation]. Poster. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting. Honolulu, US.
2008. Female sex and standardized mitomycin-c dose are associated with increased risk of neutropenia after hyperthermic intraperitoneal chemotherapy [Poster Presentation]. Conference. 61st Annual Meeting of the Society of Surgical Oncology. Chicago, US.
2008. Minimal-preparation abdomino-pelvic CT in frail and elderly patients: prognostic value of colonic and extracolonic findings [Oral Presentation]. Conference. European Congress of Radiology. Vienna, AT.
2008. Female sex and standardized mitomycin-c dose are associated with increased risk of neutropenia after hyperthermic intraperitoneal chemotherapy [Poster Presentation]. Poster. Society of Surgical Oncology 61st Annual Cancer Symposium. Chicago, US.
2008. Incidence and impact of lymph node and non-peritoneal metastases in non-carcinoid epithelial tumors of the appendix [Poster Presentation]. Poster. 61st Annual Meeting of the Society of Surgical Oncology. Chicago, US.
2008. Papillary renal cell carcinoma: radiologic and pathologic correlation and spectrum of disease [Electronic Presentation]. Conference. Abdominal Radiology Course 2008 The Society of Gastrointestinal Radiologists and The Society of Uroradiology, Joint Annual Meeting and Scientific Assembly. Rancho Mirage, US.
2008. Incidence and impact of lymph node and non-peritoneal metastases in non-carcinoid epithelial tumors of the appendix [Poster Presentation]. Poster. Gastrointestinal Cancers Symposium. Orlando, US.
2007. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease [Cum Laude Educational Exhibit Award]. Conference. Radiological Society of North America Annual Meeting. Chicago, US.
2007. A phase 1 dose-escalation study of the safety and pharmacokinetics (PK) of XL184, a VEGFR and MET kinase inhibitor, administered orally to patients (pts) with advanced malignancies [Poster Presentation]. Conference. American Association of Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer International Conference. San Francisco, US.
2007. A phase I dose-escalation study of the safety and pharmacokinetics (PK) of XL184, a VEGFR and MET kinase inhibitor, administered orally to patients (pts) with advanced malignancies [Abstract Presentation]. Conference. American Society of Clinical Oncology (ASCO) 43rd Annual Meeting. Houston, US.
2007. Phase I study of tipifarnib & sorafenib in advanced biopsiable cancer patients (NCI protocol 7156-supported by NCI grant UO1 CA062461) [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2007. Female sex and standardized mitomycin-c dose are associated with increased risk of neutropenia after hyperthermic intraperitoneal chemotherapy [Abstract Presentation]. Conference. American Society of Clinical Oncology (ASCO) 43rd Annual Meeting. Chicago, US.
2007. Is there a role for neoadjuvant chemotherapy in the management of non-carcinoid epithelial neoplasms of the appendix? [Abstract Presentation]. Conference. American Society of Clinical Oncology (ASCO) 43rd Annual Meeting. Chicago, US.
2007. Combination of 5-azacytidine (5-AZA) and valproic acid (VPA) in advanced solid cancers: a phase I study [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2007. Curcumin and pancreatic cancer: phase II clinical trial experience [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2007. Two phase I studies of MPC-6827, a novel vascular disrupting agent (VDA), in patients with advanced solid tumors and CNS metastases [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2007. Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies [Abstract Presentation]. Conference. American Society of Clinical Oncology 43rd Annual Meeting. Chicago, US.
2007. Phase I trial of imexon and docetaxel in patients with previously-treated stage IV non-small cell lung cancer, metastatic breast cancer or hormone-refractory prostate cancer [Poster Presentation]. Conference. American Association for Cancer Research Annual Meeting. Los Angeles, US.
2007. Tumor blood flow measured by functional CT and O15-labeled water PET: a comparison study [Oral Presentation]. Conference. European Congress of Radiology. Vienna, AT.
2007. Does maintenance capecitabine and celecoxib improve outcomes after complete response to treatment for metastatic colorectal cancer?. Conference. American Society of Clinical Oncology. Chicago, US.
2006. Cutaneous T cell lymphoma: responses in phase I trial of combination therapy with Liposomal Doxorubicin, Bortezomib, and Gemcitabine [Poster Presentation]. Poster. American Society of Hematology Annual Meeting. Orlando, US.
2006. Reproducibility of perfusion parameters obtained from dynamic contrast enhanced computed tomography (DCE-CT) in liver tumors [Oral Presentation]. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, US.
2006. Morphologic assessments of tumor size: scan-rescan reproducibility of long- and short-axis measurements using manual and automated 3-dimensional assessments in liver and lung tumors using magnetic resonance imaging (MRI) [Poster Presentation]. Conference. European Organization for Research and Treatment of Cancer Annual Meeting. Prague, CZ.
2006. A phase I dose-escalation study of the safety and pharmacokinetics of a XL184, a VEGFR and MET Kinase inhibitor, administered orally to subjects with advanced malignancies [Poster Presentation]. Poster. European Organization for Research and Treatment of Cancer Annual Meeting. Prague, CZ.
2006. The reproducibility of perfusion parameters obtained from dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in liver and lung tumors, and implications for sample size in clinical trials using DCE-MRI [Poster Presentation]. Poster. European Organization for Research and Treatment of Cancer Annual Meeting. Prague, CZ.
2006. Phase I study of the safety and efficacy of atiprimod, a novel azaspirine, for patients with advanced cancer [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. Atlanta, US.
2006. Phase I study of low-dose hypomethylating agent azacitidine (5-AC) combined with the histone deacetylase inhibitor valproic acid (VPA) in patients with advanced cancers [Oral Presentation]. Conference. American Society of Clinical Oncology Annual Meeting. Atlanta, US.
2006. The ability of CT to determine the degree of hepatic steatosis [Oral Presentation]. Conference. UK Radiological Congress. Birmingham, GB.
2006. The ability of CT to determine the degree of hepatic steatosis [Oral Presentation]. Conference. 106th Annual Meeting. Vancouver, CA.
2006. 1.5T vs 3T body MRI: qualitative and quantitative comparison of T2 weighted images for liver lesion detection [Poster Presentation]. Poster. International Society of Magnetic Resonance in Medicine. Seattle, US.
2006. Evaluation of liver lesions by T2-weighted imaging at 3T and 1.5T magnetic field strengths [Electronic Presentation]. Conference. American Roentgen Ray Society Annual Meeting. Vancouver, CA.
2005. Small increases in creatinine prolong ICU stay and increase hospital mortality [Oral Presentation]. Conference. American Society of Nephrology 38th Annual Renal Week Meeting. Philadelphia, US.
2005. Changes in dynamic contrast-enhanced CT (DCE-CT) parameters in patients with carcinoid liver metastases undergoing anti-VEGF versus interferon therapy [Oral Presentation]. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, US.
2005. Low hemoglobin levels are associated with higher mortality in cancer patients admitted to the surgical ICU [Oral Presentation]. Conference. American Society of Anesthesiologists. Atlanta, US.
2005. Changes in dynamic contrast-enhanced CT (DCE-CT) parameters in patients with carcinoid liver metastases undergoing anti-VEGF versus interferon therapy [Oral Presentation]. Conference. International Cancer Imaging Society Annual Meeting. Amsterdam, NL.
2005. A phase II trial of gemcitabine plus capecitabine (GX) in patients with advanced renal cell cancer (mRCC) previously treated with immunotherapy [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. Orlando, US.
2005. The spectrum of manifestations of metastatic malignant melanoma [Electronic Presentation]. Conference. American Roentgen Ray Society 105th Annual Meeting. New Orleans, US.
2005. Surgical resection of gastrointestinal stromal tumors after treatment with Imatinib [Oral Presentation]. Conference. Society of Surgical Oncology Annual Meeting. Atlanta, US.
2005. Changes in functional CT parameters and interobserver variability in patients with metastatic carcinoid treated with anti-angiogenic therapy [Electronic Presentation]. Conference. American Roentgen Ray Society Annual Meeting. New Orleans, US.
2005. Improved progression free survival (PFS), and rapid, sustained decrease in tumor perfusion among patients with advanced carcinoid treated with bevacizumab [Oral Presentation]. Conference. American Society of Clinical Oncology Annual Meeting. Orlando, US.
2004. Utility of CT or MRI staging in melanoma patients with a positive sentinel lymphadenectomy [Oral Presentation]. Conference. Sentinel Node Conference. Los Angeles, US.
2004. Changes in dynamic contrast enhanced CT (DCE-CT) parameters in patients undergoing anti-VEGFR/PDGFR therapy [Oral Presentation]. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, US.
2004. Evaluation of interobserver variability and changes in functional CT parameters in patients with metastatic carcinoid treated with anti-VEGF anti-angiogenic therapy [Poster Presentation]. Poster. Radiological Society of North America Annual Meeting. Chicago, US.
2004. Evaluation of the independent contribution of T2 weighted and dynamic post-gadolinium images in MRI - evaluation of the liver [Poster Presentation]. Poster. European Society for Magnetic Resonance in Medicine and Biology. Copenhagen, DK.
2004. A randomized phase III trial of low dose versus intermediate dose Interferon alfa (IFN) as front-line therapy in advanced progressive renal cell cancer (RCC) [Poster Presentation]. Poster. American Society of Clinical Oncology Annual Meeting. New Orleans, US.
2004. Dynamic contrast enhanced MRI evaluation of the effects of the VEGR/PDGF receptor tyrosine kinase inhibitor AG-013736 on tumor [Oral Presentation]. Conference. International Society of Magnetic Resonance in Medicine ISMRM Twelfth Scientific Meeting. Kyoto, JP.
2004. The spectrum of manifestations of metastatic malignant melanoma [Certificate of Merit Electronic Exhibit Award]. Poster. European Congress of Radiology Annual Meeting. Vienna, AT.
2003. Assessing diagnostic confidence: example from a randomised controlled trial of abdomino-pelvic CT for acute abdominal pain of uncertain etiology - being confidently wrong can be dangerous for health [Oral Presentation]. Conference. Radiological Society of North America 88th Scientific Assembly and Annual Meeting. Chicago, US.
2003. Comparison of blood flow measurements obtained by 15-10-PET and functional CT in patients with solid tumors [Oral Presentation]. Conference. Radiological Society of North America 89th Scientific Assembly and Annual Meeting. Chicago, US.
2003. Imaging approach to resectability evaluation of suprapancreatic and hilar cholangiocarcinoma [Certificate of Merit Poster Presentation Award]. Conference. Radiological Society of North America Annual Meeting. Chicago, US.
2003. Inter-observer variability in the measurement of functional CT parameters in patients with hepatic metastases [Oral Presentation]. Conference. Radiological Society of North America Annual Meeting. Chicago, US.
2003. Vascular permeability of a murine mammary tumor model assessed by functional CT using low and high molecular weight contrast media [Oral Presentation]. Conference. Radiological Society of North America Annual Meeting. Chicago, US.
2003. Comparison of blood flow measurements obtained by 150-PET and functional CT in patients with solid tumors [Oral Presentation]. Conference. Radiological Society of North America Annual Meeting. Chicago, US.
2003. Assessing diagnostic confidence: example from a randomised controlled trial of abdomino-pelvic CT for acute abdominal pain of uncertain etiology - being confidently wrong can be dangerous for health [Oral Presentation]. Conference. European Society for Gastrointestinal and Abdominal Radiology Annual Meeting. Budapest, HU.
2003. The role of computed tomography in the diagnosis and management of atypical appendicitis: case illustrations [Poster Presentation]. Poster. European Society for Gastrointestinal and Abdominal Radiology Annual Meeting. Budapest, HU.
2003. Sonography of the eye: normal anatomy and pathology [First Place Poster Presentation Award]. Conference. 10th World Federation for Ultrasound in Medicine and Biology. Montreal, CA.
2003. Accuracy of preoperative imaging of hepatic tumors with helical computed tomography [Oral Presentation]. Conference. Society of Surgical Oncology Annual Meeting. Los Angeles, US.
2002. Changes in hepatic perfusion and morphology after portal vein embolization [Oral Presentation]. Conference. Radiological Society of North America Annual Meeting. Chicago, US.
2002. Functional CT parameters and lesion enhancement measured by CT density in hepatic metastases [Oral Presentation]. Conference. Radiological Society of North America Annual Meeting. Chicago, US.
2002. Sonography of the eye: normal anatomy and pathology [Certificate of Merit Poster Presentation Award]. Conference. Radiological Society of North America Annual Meeting. Chicago, US.
2002. A prospective randomised study of early abdomino-pelvic CT in the management of patients with acute abdominal pain of indeterminate aetiology [Oral Presentation]. Conference. American Roentgen Ray Association 102nd Annual Meeting. Atlanta, US.
2002. A prospective randomised study of early abdomino-pelvic CT in the management of patients with acute abdominal pain of indeterminate aetiology [Best Scientific Paper and Oral Presentation Prize]. Conference. European Congress of Radiology. Vienna, AT.
2001. Percutaneous bone biopsy in osteomyelitis - seven years' experience [Oral Presentation]. Conference. British Society of Interventional Radiology. Cardiff, GB.
2001. Early computed tomography reduces diagnostic uncertainty in acute diverticulitis [Oral Presentation]. Conference. European Society of Gastrointestinal and Abdominal Radiology Annual Meeting. Dublin, IE.
2001. Caecal carcinoma in the elderly: serosal margin-blurring and terminal ileal wall thickening, useful signs in minimal preparation CT [Oral Presentation]. Conference. European Society of Gastrointestinal and Abdominal Radiology Annual Meeting. Dublin, IE.
2001. Appendicitis: spectrum of appearances on helical computed tomography [Poster Presentation]. Poster. United Kingdom Radiological Congress. London, GB.
2001. Extra-colonic abnormalities identified during abdomino-pelvic CT for colo-rectal carcinoma in the frail elderly patient [Oral Presentation]. Conference. United Kingdom Radiological Congress. London, GB.
2001. Evaluation of computed tomography in identifying colo-rectal carcinoma in the frail elderly patient [Oral Presentation]. Conference. American Roentgen Ray Society Annual Meeting. Seattle, US.
2001. Extra-colonic abnormalities identified during abdomino-pelvic CT for colo-rectal carcinoma in the frail elderly patient [Oral Presentation]. Conference. European Congress of Radiology. Vienna, AT.
2001. Evaluation of computed tomography in identifying colo-rectal carcinoma in the frail elderly patient [Oral Presentation]. Conference. European Congress of Radiology. Vienna, AT.
2001. Appendicitis: spectrum of appearances on helical computed tomography [Poster Presentation]. Poster. European Congress of Radiology Annual Meeting. Vienna, AT.
2001. Imaging for intended partial liver resection surgery: a retrospective analysis [Poster Presentation]. Poster. European Congress of Radiology. Vienna, AT.
2000. Computed tomography, clinical imaging and anatomy update. Conference. Third Joint British Association of Clinical Anatomists and American Association of Clinical Anatomists Meeting. Cambridge, GB.
2000. The impact of spiral computed tomography on the diagnosis of unsuspected colitis [Oral Presentation]. Conference. European Society of Gastrointestinal and Abdominal Radiology Annual Meeting. La Grande Motte, FR.
1999. Malignant pleural mesothelioma: the spectrum of manifestations on computed tomography in 70 cases [Poster Presentation]. Conference. European Respiratory Society. Madrid, ES.
1999. Gamma camera positron emission tomography (PET) in lymphoma [Oral Presentation]. Conference. European Association of Nuclear Medicine Annual Congress. Barcelona, ES.
1999. Lung cancer after breast cancer: the role of smoking and radiotherapy [Poster Presentation]. Conference. European Cancer Conference. Vienna, AT.
1999. Gamma camera positron emission tomography (PET) in lymphoma [Oral Presentation]. Conference. British Cancer Research Meeting. Edinburgh, GB.
1999. Gamma camera positron emission tomography (PET) in lymphoma [Oral Presentation]. Conference. Society of Nuclear Medicine Annual Meeting. Los Angeles, US.
1999. Lung cancer after breast cancer: does smoking or radiation therapy increase the risk of bronchoalveolar carcinoma? [Poster Presentation]. Poster. Society for Epidemiologic Research Annual Meeting. Baltimore, US.
1999. Malignant pleural mesothelioma: the spectrum of manifestations on CT in 70 cases [Certificate of Merit Poster Presentation Award]. Poster. American Roentgen Ray Society Annual Meeting. New Orleans, US.
1999. Gamma camera positron emission tomography (PET) in lymphoma [Oral Presentation]. Conference. Twenty-Seventh Annual Meeting of the BNMS. Brighton, GB.
1999. Lung cancer after breast cancer: the role of smoking and radiotherapy [Poster Presentation]. Poster. American Society for Preventive Oncology Annual Meeting. Houston, US.
1999. Malignant pleural mesothelioma: the spectrum of manifestations on computed tomography in 70 cases [Poster Presentation]. Conference. European Congress of Radiology. Vienna, AT.
1999. MR imaging of tumors involving the perineum: imaging anatomy, diagnosis and staging, treatment evaluation and surgical correlation [Cum Laude Poster Presentation Award]. Poster. European Congress of Radiology. Vienna, AT.
1998. MRI imaging of tumors involving the perineum: imaging anatomy, diagnosis and staging, treatment evaluation and surgical correlation [Poster Presentation]. Conference. Radiological Society of North America Annual Meeting. Chicago, US.
1998. The appearances of renal cell carcinoma metastases in the pancreas using 3-phase intravenous enhanced helical computed tomography [Poster Presentation]. Conference. Radiology Annual Meeting. Birmingham, GB.
1998. Venous invasion in pancreatic carcinoma: computed tomography-pathologic correlation [Oral Presentation]. Conference. Radiology 1998 - Imaging, Science & Oncology. Birmingham, GB.
1998. MRI Imaging of tumors involving the perineum: imaging anatomy, diagnosis and staging, treatment evaluation, and surgical correlation [Poster Presentation]. Conference. American Roentgen Ray Society Annual Meeting. San Francisco, US.
1998. Venous invasion in pancreatic carcinoma: computed tomography-pathologic correlation [Oral Presentation]. Conference. American Roentgen Ray Society Annual Meeting. San Francisco, US.
1998. A computed tomography sign of pulmonary hypertension: the ratio of main pulmonary artery to aortic diameter [Oral Presentation]. Conference. Society of Thoracic Radiology Annual Meeting. San Juan, US.
1998. Hepatic lesion detection: T2 weighted fast spin echo vs. breathhold single shot fast spin echo [Oral Presentation]. Conference. Association of University Radiologists Annual Meeting. New Orleans, US.
1997. The results of 500 percutaneous bone biopsies [Oral Presentation]. Conference. Annual Scientific Meeting of Hong Kong College of Radiologists, HK.
1997. Correlation of computed tomography with histopathological findings in patients with gastric and esophageal carcinomas following neo-adjuvant chemotherapy [Highly Commended Poster Presentation Award]. Conference. Radiology Annual Meeting. Birmingham, GB.
1997. A CT sign of pulmonary hypertension: the ratio of main pulmonary artery to aortic diameter [Oral Presentation]. Conference. Radiology Annual Meeting. Birmingham, GB.
1997. The detection of signs of small airways disease: a comparison of inspiratory and expiratory thin-section computed tomography [Oral Presentation]. Conference. Radiology Annual Meeting. Birmingham, GB.
1997. The investigation of reno-vascular hypertension in children: the accuracy of radioisotopes in detecting reno-vascular disease [Oral Presentation]. Conference. British Nuclear Medicine Society. Brighton, GB.
1997. Correlation of computed tomography with histopathological findings in patients with gastric and oesophageal carcinomas following neo-adjuvant chemotherapy [Oral Presentation]. Conference. European Congress of Radiology Annual Meeting. Vienna, AT.
1997. The detection of signs of small airways disease: a comparison of inspiratory and expiratory thin-section computed tomography [Oral Presentation]. Conference. European Congress of Radiology. Vienna, AT.
1997. The detection of signs of small airway disease: a comparison of inspiratory and expiratory thin-section computed tomography [Poster Presentation]. Poster. Society of Thoracic Radiology Annual Meeting. Amelia Island, US.
1996. The value of Doppler ultrasound in assessing the severity of liver disease in patients with primary biliary cirrhosis [Oral Presentation]. Conference. British Medical Ultrasound Society. Edinburgh, GB.
1996. Inter- and intra-observer accuracy in the Doppler measurement of hepatic artery resistance index, portal vein velocity, portal vein diameter, and spleen size [Oral Presentation]. Conference. British Medical Ultrasound Society. Edinburgh, GB.
1995. Is this really breast disease? Manifestations of extra-mammary disease on imaging the breast [Poster Presentation]. Conference. Radiological Society of North America Annual Meeting. Chicago, US.
1995. Radiologically guided bone biopsies - results of 477 biopsies [Poster Presentation]. Poster. Roentgen Centenary Congress. Birmingham, GB.
1994. Mammographic manifestations of extra-mammary diseases [Poster Presentation]. Poster. Symposium Mammographicum. York, GB.
1994. Relationship between the level of suspicion for screening detected mammographic abnormalities and positive value of malignancy [Poster Presentation]. Conference. Symposium Mammographicum. York, GB.
1994. The predictive value of mammographic signs for women referred for surgical biopsy following breast screening [Oral Presentation]. Conference. Symposium Mammographicum. York, GB.
1990. Growth hormone responses to pyridostigmine in myasthenia gravis [Oral Presentation]. Conference. Society for Endocrinology Annual Meeting. London, GB.

Formal Peers

2008. Imaging of Bladder Cancer. Invited. Philadelphia, PA, US.
2008. Imaging primary Renal Cell Cancer. Invited. Philadelphia, PA, US.
2008. The CT Urogram: Technique Applications & Findings. Invited. Philadelphia, PA, US.
2006. Unusual Renal masses. Invited. Washington, DC, US.
2006. Imaging and Staging of Uroepithelial Tumors. Invited. Washington, DC, US.
2004. Cross sectional imaging of the liver I and II. Invited. Anchorage, AK, US.
2004. Cross sectional imaging of the pancreas. Invited. Anchorage, AK, US.
2004. Interesting cases from MD Anderson. Invited. Anchorage, AK, US.
2004. Conservative renal cancer staging. Invited. Anchorage, AK, US.
2004. Unknown case studies. Invited. Anchorage, AK, US.
2004. Biliary cancer: multislice CT and MRI. Invited. Anchorage, AK, US.
2004. Staging of renal cancer. Invited. Anchorage, AK, US.
2003. Staging of Renal Carcinoma. Invited. San Antonio, TX, US.
2003. Conservative Renal Cancer Staging: what you need to provide the surgeon. Invited. San Antonio, TX, US.

Less

Grant & Contract Support

Date:	2023 - 2024
Title:	AI-Driven Reliable CT Perfusion Measurements for Tumors with Motion
Funding Source:	UT MD Anderson QIAC Partnership in Research Program
Role:	Co-PI

Date:	2022 - 2023
Title:	AI-Driven Reliable CT Perfusion Measurements for Tumors with Motion
Funding Source:	UT MD Anderson QIAC Partnership in Research Program
Role:	Co-PI

Date:	2018 - 2021
Title:	CT Perfusion to assess Response in Recurrent Platinum-resistant Ovarian Cancer
Funding Source:	Department of Defense (DOD)
Role:	Co-PI
ID:	W81XWH-18-OCRP-CDA

Date:	2018 - 2019
Title:	Southwest Early Clinical Trials Consortium
Funding Source:	NIH/NCI
Role:	Co-I
ID:	5UM1CA186688-04 (RFA-CA-13-006)

Date:	2016 - 2018
Title:	Southwest Early Clinical Trial - Phase 2 Consortium
Funding Source:	NIH/NCI
Role:	Co-I
ID:	3UM1CA186688-03S1 (RFA-CA-15-501)

Date:	2014 - 2015
Title:	Feasibility of using dual energy CT (DECT) for measuring contrast enhancement in single phase CT exams
Funding Source:	General Electric Healthcare/Center for Advanced Biomedical Imaging (CABI) - WS#9
Role:	PI
ID:	PA13-0655

Date:	2014 - 2017
Title:	Southwest Early Clinical Trial
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	UM1 CA186688

Date:	2014 - 2015
Title:	Southwest Early Clinical Trials Consortium
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1UM1CA186688-01 (RFA-CA-13-006)

Date:	2013 - 2016
Title:	Pilot study assessing the feasibility and technical efficacy of computed tomography (CT) shuttle mode and application to CT perfusion imaging
Funding Source:	Center for Advanced Biomedical Imaging (CABI)
Role:	PI
ID:	2008-0727

Date:	2013 - 2015
Title:	Pilot study assessing the feasibility and technical efficacy of computed tomography (CT) shuttle mode, and application to CT perfusion imaging
Funding Source:	General Electric Healthcare/Center for Advanced Biomedical Imaging (CABI)
Role:	PI
ID:	2008-0727

Date:	2012 - 2015
Title:	Patterns and outcomes of treatment sequencing in metastatic melanoma
Funding Source:	Genentech, Inc
Role:	Collaborator
ID:	C4-159443

Date:	2011 - 2017
Title:	Clinical translation of therapeutic siRNA in solid malignancies
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I
ID:	RP120214-02

Date:	2011 - 2012
Title:	Project 4 (Bar-Eli) Targeting Angiogenesis and the Tumor Microenvironment Utilizing siRNA Nanoliposomes as a New Modality for Treatment of Melanoma
Funding Source:	National Cancer Institute-DHHS-NIH
Role:	Collaborator
ID:	P50CA093459

Date:	2011 - 2013
Title:	ACRIN 6695: Perfusion CT imaging to evaluate treatment response in patients participating in GOG-0262, a phase III trial of every 3-weeks Paclitaxel versus dose dense weekly Paclitaxel in combination with Carboplatin with or without concurrent and consolidation Bevacizumab (NSC #704865, IND #7921) in the treatment of primary stage II, III or IV epithelial ovarian, peritoneal or fallopian tube cancer
Funding Source:	American College of Radiology Imaging Network (ACRIN)
Role:	PI
ID:	5 U01 CA080098 12

Date:	2011 - 2011
Title:	Accelerated Accrual Demonstration Project
Funding Source:	American College of Radiology Imaging Network (ACRIN)
Role:	PI
ID:	5 U01 CA080098 13

Date:	2010 - 2016
Title:	Pilot study assessing the technical efficacy of computed tomography urography (CTU) vs intravenous urography (IVU), with particular focus on patients at risk of urothelial tumors
Funding Source:	Diagnostic Imaging Clinical Research Committee (DICRC)
Role:	PI
ID:	DICRC-02-2010

Date:	2010 - 2015
Title:	UT MD Anderson Cancer Center SPORE in melanoma
Funding Source:	NIH/NCI
Role:	Co-I
ID:	P50CA093459

Date:	2008 - 2010
Title:	Pilot study assessing the technical efficacy of computed tomography urography (CTU) vs intravenous urography (IVU), with particular focus on patients at risk of urothelial tumors
Funding Source:	General Electric Healthcare
Role:	PI
ID:	CS2008-00023493MA

Date:	2008 - 2010
Title:	Pilot study assessing the feasibility and technical efficacy of computed tomography (CT) shuttle mode, and application to CT perfusion imaging
Funding Source:	General Electric Healthcare
Role:	PI
ID:	WS#1 CS2009-00027151EB

Date:	2006 - 2010
Title:	International Center of TCM for Cancer
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	1 U19 CA121503

Date:	2006 - 2007
Title:	Phase II trial of sunitinib malate (Sutent) therapy in patients with advanced non-clear cell renal cell carcinoma
Funding Source:	Pfizer Pharmaceuticals
Role:	Collaborator
ID:	CS2006-00018400JW

Date:	2006 - 2011
Title:	A phase II study of SU011248 in Von Hippel-Lindau Syndrome
Funding Source:	Pfizer Pharmaceuticals
Role:	Collaborator
ID:	2005-0463

Date:	2005 - 2009
Title:	Pg-Gd: a novel MRI blood-pool agent with wide applicability to non-invasive vascular and functional imaging and delineation of tissue necrosis
Funding Source:	MD Anderson Cancer Center, Technology Review Committee
Role:	Collaborator

Date:	2005 - 2010
Title:	Objective evaluation of DCE-CT and DCE-MRI in assessing tumor perfusion and permeability changes with AZ drugs in the angiogenesis biological effect area in an animal model
Funding Source:	AstraZeneca
Role:	Project Leader
ID:	LS2006-00016301PP-6

Date:	2005 - 2007
Title:	Dynamic contrast enhancement computed tomography in patients with metastatic renal cell carcinoma receiving targeted therapy (Companion to Protocol 2003-0982)
Funding Source:	MD Anderson Cancer Center
Role:	Co-I

Date:	2004 - 2007
Title:	Reproducibility of functional and structural imaging parameters from dynamic contrast enhancement magnetic resonance imaging (dceMRI) in lung and liver computed tomography (dceCT) parameters in lung malignancies
Funding Source:	Pfizer Pharmaceuticals
Role:	PI
ID:	CS2004-00010744HM

Date:	2004 - 2005
Title:	Reproducibility of functional parameters from dynamic contrast enhancement computed tomography (dceCT) in liver malignancies (Companion to Protocol 2003-0885)
Funding Source:	General Electric Systems, Mike Hogg Fund
Role:	PI

Date:	2004 - 2006
Title:	Reproducibility of functional parameters from dynamic contrast enhancement magnetic resonance imaging (dceMRI), and a comparison with dynamic contrast enhancement computed tomography
Funding Source:	Mike Hogg Fund
Role:	PI

Date:	2003 - 2008
Title:	Quantitative CT perfusion in the liver
Funding Source:	General Electric Medical Systems
Role:	Co-I

Date:	2003 - 2005
Title:	Traditional Chinese Medicine
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	1 R21 CA108084

Date:	2002 - 2003
Title:	Visualizing prostate cancer metastasis to bone in mouse models
Funding Source:	MD Anderson Cancer Center Prostate Cancer Research Program
Role:	Collaborator

Date:	2001 - 2007
Title:	Imaging prostate gene therapy vector distributions with MRI
Funding Source:	National Institute of Biomedical Imaging and Bioengineering - DHHS - NIH, MD Anderson Cancer Center Prostate Cancer Research Project SPORE
Role:	Collaborator
ID:	5 P50 CA090270 04(PP-DR12)

Date:	1994 - 2015
Title:	Phase I studies of targeted anti-cancer therapies
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	N01 5 U01 CA062461

Date:	1994 - 2013
Title:	Phase 1 Studies of Targeted Anti-Cancer Therapies: Clinical Trials Core
Funding Source:	NIH/NCI/DHHS
Role:	Collaborator
ID:	5U01CA062461-18(PP-C)

Title:	Statistical modeling of functional imaging biomarkers
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	PA14-0097

Selected Publications

Peer-Reviewed Articles

Ahmed J, Stephen B, Khawaja MR, Yang Y, Salih I, Barrientos-Toro E, Raso MG, Karp DD, Piha-Paul SA, Sood AK, Ng CS, Johnson A, Soliman PT, Meric-Bernstam F, Lu KH, Naing A. A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer. Gynecol Oncol 193:73-80, 2025. e-Pub 2025. PMID: 39787747.
Clemente-Gutierrez U, Pieterman CRC, Lui MS, Yamashita TS, Tame-Elorduy A, Huang BL, Shirali AS, Erstad DJ, Lee JE, Fisher SB, Graham PH, Grubbs EG, Waguespack SG, Ng CS, Perrier N. Beyond the three P's: adrenal involvement in MEN1. Endocr Relat Cancer 31(2), 2024. e-Pub 2024. PMID: 38108666.
Ng CS, Chandler AG, Chen Y, Wei W, Tannir NM, Hobbs BP. Effect of scan duration on CT perfusion values in metastases from renal cell carcinoma. Res Diagn Interv Imaging 6:100028, 2023. e-Pub 2023. PMID: 39077545.
Ng CS, Chandler AG Chen Y, Wei W, Tannir NM Hobbs BP. Effect of scan duration on CT perfusion values in metastases from renal cell carcinoma. Research in Diagnostic and Interventional Imaging 6:100028, 2023. e-Pub 2023.
McCullough P, Ng C, Ryan M, Baker E, Mehta R. Major adverse renal and cardiovascular events following intra-arterial contrast media administration in hospitalized patients with comorbid conditions. Cardiorenal Medicine:1-7, 2021. e-Pub 2021.
Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Author response to Cunha et al. J Immunother Cancer 9(7), 2021. e-Pub 2021. PMID: 34315823.
Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Radiomics Analysis for Predicting Pembrolizumab Response in Patients with Advanced Rare Cancers. J Immunother Cancer 9(4), 2021. e-Pub 2021. PMID: 33849924.
Li X, Guindani M, Ng CS, Hobbs B. A bayesian nonparametric model for textural pattern heterogeneity. Journal of the Royal Statistical Society: Series C (Applied Statistics), 2021. e-Pub 2021.
McCullough P, Ng CS, Ryan M, Baker ER, Mehta R. Major Adverse Renal and Cardiovascular Events following Intra-Arterial Contrast Media Administration in Hospitalized Patients with Comorbid Conditions. Cardiorenal Med 11(4):193-199, 2021. e-Pub 2021. PMID: 34433166.
Altinmakas E, Perrier ND, Grubbs EG, Lee JE, Prieto VG, Ng CS. Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma. Acta Radiol 61(8):1080-1086, 2020. e-Pub 2020. PMID: 31791129.
Wang Y, Hu J, Ng CS, Hobbs BP. A functional model for classifying metastatic lesions integrating scans and biomarkers. Stat Methods Med Res 29(1):137-150, 2020. e-Pub 2020. PMID: 30672395.
Popnoe DO, Ng CS, Zhou S, Kaur H, Kang HC, Loyer EM, Kappadath SC, Jones AK. Comparison of virtual to true unenhanced abdominal computed tomography images acquired using rapid kV-switching dual energy imaging. PLoS One 15(9):e0238582, 2020. e-Pub 2020. PMID: 32966278.
Olivia Popnoe D, Ng CS, Zhou S, Cheenu Kappadath S, Pan T, Kyle Jones A. Comparison of enhancement quantification from virtual unenhanced images to true unenhanced images in multiphase renal Dual-Energy computed tomography: A phantom study. J Appl Clin Med Phys 20(8):171-179, 2019. e-Pub 2019. PMID: 31423728.
Altinmakas E, Ucisik-Keser FE, Medeiros LJ, Ng CS. CT and (18)F- FDG-PET-CT Findings in Secondary Adrenal Lymphoma with Pathologic Correlation. Acad Radiol 26(6):e108-e114, 2019. e-Pub 2019. PMID: 30076085.
Petros FG, Venkatesan AM, Kaya D, Ng CS, Fellman BM, Karam JA, Wood CG, Matin SF. Conditional survival of patients with small renal masses undergoing active surveillance. BJU Int 123(3):447-455, 2019. e-Pub 2019. PMID: 30007044.
Halperin DM, Lee JJ, Ng CS, Strosberg JR, Estrella JS, Dagohoy CG, Dasari A, Yao JC. A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors. Pancreas 48(3):381-386, 2019. e-Pub 2019. PMID: 30768575.
Christakis I, Graham PH, Lee JE, Perrier ND, Ng CS, Grubbs EG. Operation duration and adrenal gland size, but not BMI, are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases. Surgery 165(3):637-643, 2018. e-Pub 2018.
Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier ND, Lee JE, Prieto VG, Hobbs BP. Utility of intermediate-delay washout computed tomography images for differentiation of malignant and benign adrenal lesions: A multivariate analysis. AJR Am J Roentgenol 211(2):W1-W7, 2018. e-Pub 2018. PMID: 29949418.
Ng CS, Kalva SP, Gunnarsson C, Ryan MP, Baker ER, Mehta RL. Risk of Renal Events Following Intravenous Iodinated Contrast Material Administration among Inpatients Admitted with Cancer a Retrospective Hospital Claims Analysis. Cancer Imaging 18(1):30, 2018. e-Pub 2018. PMID: 30143056.
Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier NA, Prieto VG, Lee JE, Hobbs BP. Combining Washout and Noncontrast Data From Adrenal Protocol Computed Tomography: Improving Diagnostic Performance. Acad Radiol 25(7):861-868, 2018. e-Pub 2018. PMID: 29398440.
Ng CS, Wei W, Duran C, Ghosh P, Anderson EF, Chandler AG, Yao JC. Computed tomography perfusion in normal liver and liver metastases from neuroendocrine tumors treated with targeted antivascular agents. Abdom Radiol (NY) 43(7):1661-1669, 2018. e-Pub 2018. PMID: 29075824.
Ghosh P, Chandler AG, Hobbs BP, Sun J, Rong J, Hong D, Subbiah V, Janku F, Naing A, Hwu WJ, Ng CS. Quantification of the effect of shuttling on computed tomography perfusion parameters by investigation of aortic inputs on different table positions from shuttle-mode scans of lung and liver tumors. J Comput Assist Tomogr 42(3):357-364, 2018. e-Pub 2018. PMID: 29189398.
Li X, Guindani M, Ng CS, Hobbs BP. Spatial Bayesian modeling of GLCM with application to malignant lesion characterization. J Appl Statist:1-17, 2018. e-Pub 2018.
Chen N, Hobbs B, Ng CS. Bayesian classifiers of solid lesions with dynamic computed tomography: Integrating enhancement density with washout density and delay interval. 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI), 2018. e-Pub 2018.
Ng CS, Wei W, Altinmakas E, Li X, Ghosh P, Perrier NA, Grubbs E, Prieto VG, Lee JE, Hobbs BP. Differentiation of Malignant and Benign Adrenal Lesions With Delayed Computed Tomography: Multivariate Analysis and Predictive Models. AJR Am J Roentgenol 210(4):W156-W163, 2018. e-Pub 2018. PMID: 29412015.
Chen N, CS N, Hobbs BP. Bayesian classifiers of solid lesions with dynamic CT: integrating enhancement density with washout density and delay interval. 2018 IEEE 15th International Symposium on Biomedical Imaging:236-239. e-Pub 2018.
Patnana M, Rao Korivi B, Devine CE, Faria S, Prieto V, Ross M, Ng CS. Metastatic melanoma to the testis. BJR|case reports, 2018. e-Pub 2018.
Ng CS, Wei W, Ghosh P, Anderson E, Herron DH, Chandler AG. Observer Variability in Computed Tomography Perfusion Parameters in Primary and Metastatic Tumors in the Lung. Technol Cancer Res Treat 17:1533034618769767, 2018. e-Pub 2018. PMID: 29681221.
Mackin D, Fave X, Zhang L, Yang J, Jones AK, Ng CS, Court L. Correction: Harmonizing the pixel size in retrospective computed tomography radiomics studies. PLoS One 13(1):e0191597, 2018. e-Pub 2018. PMID: 29342209.
Shoemaker K, Hobbs BP, Bharath K, Ng CS, Baladandayuthapani V. Tree-based methods for characterizing tumor density heterogeneity. Pac Symp Biocomput 23:216-227, 2018. e-Pub 2018. PMID: 29218883.
Li X, Guindani M, Ng CS, Hobbs BP. Spatial Bayesian modeling of GLCM with application to malignant lesion characterization. J Appl Stat 46(2):230-246, 2018. e-Pub 2018. PMID: 31439980.
Ng CS, Zhang Z, Lee SI, Marques HS, Burgers K, Su F, Bauza J, Mannel RS, Walker JL, Huh WK, Rubin SC, DiSilvestro P, Martin LP, Chan JK, Bookman MA, Coleman RL, Lee TY. CT perfusion as an early biomarker of treatment efficacy in advanced ovarian cancer: an ACRIN and GOG study. Clin Cancer Res 23(14):3684-3691, 2017. e-Pub 2017. PMID: 28174234.
Ehrmann S, Quartin A, Hobbs BP, Robert-Edan V, Cely C, Bell C, Lyons G, Pham T, Schein R, Geng Y, Lakhal K, Ng CS. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med 43(6):785-794, 2017. e-Pub 2017. PMID: 28197679.
Li X, Guindani M, Ng CS, Hobbs B. Classification of adrenal lesions through spatial Bayesian modeling of GLCM. 2017 IEEE International Symposium on Biomedical Imaging, 2017. e-Pub 2017.
Altinmakas E, Hobbs BP, Ye H, Grubbs EG, Perrier ND, Prieto VG, Lee JE, Ng CS. Diagnostic performance of (18-)F-FDG-PET-CT in adrenal lesions using histopathology as reference standard. Abdom Radiol (NY) 42(2):577-584, 2017. e-Pub 2017. PMID: 27665482.
Mackin D, Fave X, Zhang L, Yang J, Jones AK, Ng CS, Court L. Harmonizing the pixel size in retrospective computed tomography radiomics studies. PLoS One 12(9):e0178524, 2017. e-Pub 2017. PMID: 28934225.
Ghosh P, Chandler AG, Altinmakas E, Rong J, Ng CS. Correction of Motion Artifacts From Shuttle Mode Computed Tomography Acquisitions for Body Perfusion Imaging Applications. J Comput Assist Tomogr 40(3):471-7, 2016. e-Pub 2016. PMID: 27192503.
Tannir NM, Jonasch E, Albiges L, Altinmakas E, Ng CS, Matin SF, Wang X, Qiao W, Dubauskas Lim Z, Tamboli P, Rao P, Sircar K, Karam JA, McDermott DF, Wood CG, Choueiri TK. Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (ESPN): a randomized multicenter phase 2 trial. Eur Urol 69(5):866-74, 2016. e-Pub 2016. PMID: 26626617.
Khawaja MR, Nick AM, Madhusudanannair V, Fu S, Hong D, McQuinn LM, Ng CS, Piha-Paul SA, Janku F, Subbiah V, Tsimberidou A, Karp D, Meric-Bernstam F, Lu KH, Naing A. Phase I dose escalation study of Temsirolimus in combination with Metformin in patients with advanced/refractory cancers. Cancer Chemother Pharmacol 77(5):973-7, 2016. e-Pub 2016. PMID: 27014780.
Yang J, Zhang L, Fave XJ, Fried DV, Stingo FC, Ng CS, Court LE. Uncertainty analysis of quantitative imaging features extracted from contrast-enhanced CT in lung tumors. Comput Med Imaging Graph 48:1-8, 2016. e-Pub 2016. PMID: 26745258.
Altinmakas E, Guo M, Kundu UR, Habra MA, Ng C. Computed tomography and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings in adrenal candidiasis and histoplasmosis: two cases. Clin Imaging 39(6):1115-1118, 2015. e-Pub 2015. PMID: 26298420.
Wang Y, Hobbs BP, Hu J, Ng CS, Do KA. Predictive classification of correlated targets with application to detection of metastatic cancer using functional CT imaging. Biometrics 71(3):792-802, 2015. e-Pub 2015. PMID: 25851056.
Vodopivec DM, Habra MA, Ng C, Sircar K, Grubbs EG. Visual Vignette. Endocr Pract 21(7):854, 2015. e-Pub 2015. PMID: 26121444.
Ng CS, Wei W, Bankson JA, Ravoori MK, Han L, Brammer DW, Klumpp S, Waterton JC, Jackson EF. Dependence of DCE-MRI biomarker values on analysis algorithm. PLoS One 10(7):1-16, 2015. e-Pub 2015. PMID: 26208254.
Ng CS, Hobbs BP, Wei W, Anderson EF, Herron DH, Yao JC, Chandler AG. Effect on perfusion values of sampling interval of computed tomographic perfusion acquisitions in neuroendocrine liver metastases and normal liver. J Comput Assist Tomogr 39(3):373-382, 2015. e-Pub 2015. PMID: 25626401.
Phan AT, Halperin DM, Chan JA, Fogelman DR, Hess KR, Malinowski P, Regan E, Ng CS, Yao JC, Kulke MH. Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study. Lancet Oncol 16(6):695-703, 2015. e-Pub 2015. PMID: 25956795.
Hobbs BP, Ng, C. Inferring stable acquisition durations for applications of perfusion imaging in oncology. Cancer Informatics 14(Suppl 2):193-199, 2015. e-Pub 2015. PMID: 26052222.
Bilen MA, Fu S, Falchook GS, Ng CS, Wheler JJ, Abdelrahim M, Erguvan-Dogan B, Hong DS, Tsimberidou AM, Kurzrock R, Naing A. Phase I trial of valproic acid and lenalidomide in patients with advanced cancer. Cancer Chemother Pharmacol 75(4):869-874, 2015. e-Pub 2015. PMID: 25666183.
Yao JC, Phan AT, Hess K, Fogelman D, Jacobs C, Dagohoy C, Leary C, Xie K, Ng CS. Perfusion CT as functional biomarker in randomized run-in study of Bevacizumab and Everolimus in well-differentiated neuroendocrine tumors. Pancreas 44(2):190-197, 2015. e-Pub 2015. PMID: 25426617.
Shah AY, Karam JA, Lim ZD, Ng CS, Tannir NM. Clinical and pathological complete remission in a patient with metastatic renal cell carcinoma (mRCC) treated with sunitinib: Is mRCC curable with targeted therapy?. Urol Case Rep 3(2):18-20, 2015. e-Pub 2015. PMID: 26120560.
Wagner-Bartak NA, Toshav AM, Tamm EP, Le O, Agarwal S, Ng C, Qayyum A. CT liver imaging: What is new?. Current Radiology Reports 3(3):1-13, 2015. e-Pub 2015.
Wang Y, Hobbs BP, Ng CS. CT perfusion characteristics identify metastatic sites in liver. Biomed Res Int 2015:1-6, 2015. e-Pub 2015. PMID: 26509144.
Fronczyk KM, Guindani M, Hobbs BP, Ng CS, Vannucci M. A Bayesian nonparametric approach for functional data classification with application to hepatic tissue characterization. Cancer Inform 14(Suppl 5):151-62, 2015. e-Pub 2015. PMID: 27279730.
Falchook GS, Wheler JJ, Naing A, Jackson EF, Janku F, Hong D, Ng CS, Tannir NM, Lawhorn KN, Huang M, Angelo LS, Vishwamitra D, Hess K, Howard AN, Parkhurst KL, Amin HM, Kurzrock R. Targeting hypoxia-inducible Factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of Bortezomib plus Bevacizumab. Oncotarget 5(21):10280-92, 2014. e-Pub 2014. PMID: 25373733.
Ng CS, Chandler AG, Yao JC, Herron DH, Anderson EF, Charnsangavej C, Hobbs BP. Effect of pre-enhancement set-point on computed tomography perfusion values in normal liver and metastases to the liver from neuroendocrine tumors. J Comput Assist Tomogr 38(4):526-534, 2014. e-Pub 2014. PMID: 24651739.
Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. World J Surg 38(6):1318-1327, 2014. e-Pub 2014. PMID: 24615603.
Haygood TM, Liu MAQ, Galvan E, Bassett R, Murphy WA, Ng C, Matamoros A, Marom EM. Consistency of response and image recognition, pulmonary nodules. Br J Radiol 87(1038), 2014. e-Pub 2014. PMID: 24697724.
Carthon BC, Ng CS, Pettaway CA, Pagliaro LC. Epidermal growth factor receptor - targeted therapy in locally advanced or metastatic squamous cell carcinoma of the Penis. BJU Int 113(6):871-877, 2014. e-Pub 2014. PMID: 24053151.
Atkinson B, Cauley DH, Ng CS, Millikan RE, Xiao L, Corn P, Jonasch EN, Tannir, NM. Mammalian target of rapamycin (mTOR) inhibitor-associated noninfectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes. Br J Urol Int 113(3):376-382, 2014. e-Pub 2014. PMID: 24053120.
Ng CS, Hobbs BP, Chandler AG, Anderson EF, Herron DH, Charnsangavej C, Yao J. Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion values. Radiology 269(3):758-767, 2013. e-Pub 2013. PMID: 23824990.
Ng CS, Chandler AG, Wei W, Anderson EF, Herron DH, Kurzrock R, Charnsangavej C. Effect of duration of scan acquisition on CT perfusion parameter values in primary and metastatic tumors in the lung. Eur J Radiol 82(10):1811-1818, 2013. e-Pub 2013. PMID: 23769187.
Richey SL, Tamboli P, Ng CS, Lin E, Lim ZD, Araujo JC, Jonasch E, Sharma P, Pagliaro LC, Tannir NM. Phase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinoma. Am J Clin Oncol 36(5):450-454, 2013. e-Pub 2013. PMID: 22706175.
Dickstein R, Ng C, Dinney C, Kamat A. Accuracy of computed tomography for identifying locally advanced disease in patients with muscle-invasive bladder cancer. UroToday Int J 6(5):art 55, 2013. e-Pub 2013.
Conter HJ, Lim ZD, Ng CS, Millikan RE, Tannir NM. Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission. Clin Genitourin Cancer 11(3):370-373, 2013. e-Pub 2013. PMID: 23665133.
Ng CS, Chandler A, Wei W, Herron DH, Anderson EF, Kurzrock R, Charnsangavej C. Effect of sampling frequency on perfusion values in CT perfusion of lung tumors. AJR 200(2):W155-62, 2013. e-Pub 2013. PMID: 23345379.
Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg 216(2):280-9, 2013. e-Pub 2013. PMID: 23317575.
Le O, Bhosale P, Szklaruk J, Ng CS, Tamm E. MDCT: Impact of new technologies on oncologic imaging—practical considerations. Applied Radiology 42(1):24-34, 2013. e-Pub 2013.
Tannir NM, Plimack E, Ng C, Tamboli P, Bekele NB, Xiao L, Smith L, Lim Z, Pagliaro L, Araujo J, Aparicio A, Matin S, Wood CG, Jonasch E. A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma. Eur Urol. e-Pub 2012.
Jakob JA, Bassett RL, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, Lazar AJ, Hwu P, Davies MA. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer 118(16):4014-23, 2012. e-Pub 2012. PMID: 22180178.
Kim KB, Prieto V, Joseph RW, Diwan AH, Gallick GE, Papadopoulos NE, Bedikian AY, Camacho LH, Hwu P, Ng CS, Wei W, Johnson MM, Wittemer SM, Vardeleon A, Reckeweg A, Colevas AD. A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma. Melanoma Res 22(4):294-301, 2012. e-Pub 2012. PMID: 22668797.
Chandler A, Wei W, Anderson EF, Herron DH, Ye Z, Ng CS. Validation of motion correction techniques for liver CT perfusion studies. Br J Radiol 85(1016):e514-22, 2012. e-Pub 2012. PMID: 22374283.
Ng CS, Chandler AG, Wei W, Anderson EF, Herron DH, Kurzrock R, Charnsangavej C. Effect of dual vascular input functions on CT perfusion parameter values and reproducibility in liver tumors and normal liver. J Comput Assist Tomogr 36(4):388-93, 2012. e-Pub 2012. PMID: 22805665.
Fu S, Hennessy BT, Ng CS, Ju Z, Coombes KR, Wolf JK, Sood AK, Levenback CF, Coleman RL, Kavanagh JJ, Gershenson DM, Markman M, Dice K, Howard A, Li J, Li Y, Stemke-Hale K, Dyer M, Atkinson E, Jackson E, Kundra V, Kurzrock R, Bast RC, Mills GB. Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. Gynecol Oncol 126(1):47-53, 2012. e-Pub 2012. PMID: 22487539.
Meng Z, Garrett CR, Shen Y, Liu L, Yang P, Huo Y, Zhao Q, Spelman AR, Ng CS, Chang DZ, Cohen L. Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas. Br J Cancer 107(3):411-6, 2012. e-Pub 2012. PMID: 22782343.
Jain RK, Lee JJ, Ng C, Hong D, Gong J, Naing A, Wheler J, Kurzrock R. Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies. J Clin Oncol 30(21):2684-90, 2012. e-Pub 2012. PMID: 22689801.
Ng CS, Waterton JC, Kundra V, Brammer D, Ravoori M, Han L, Wei W, Klumpp S, Johnson VE, Jackson EF. Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model. Technol Cancer Res Treat 11(3):279-88, 2012. e-Pub 2012. PMID: 22417064.
Bronstein Y, Ng CS, Rohren E, Ross MI, Lee JE, Cormier J, Johnson VE, Hwu WJ. Positron emission tomography/computed tomography in the Management of Patients With Stage IIIC and IV Metastatic Melanoma Considered Candidates for Surgery: Evaluation of the Additive Value After Conventional Imaging. AJR Am J Roentgenol 198(4):902-8, 2012. e-Pub 2012. PMID: 22451559.
Davies MA, Fox PS, Papadopoulos NE, Bedikian AY, Hwu WJ, Lazar AJ, Prieto VG, Culotta KS, Madden TL, Xu Q, Huang S, Deng W, Ng CS, Gupta S, Liu W, Dancey JE, Wright JJ, Bassett RL, Hwu P, Kim KB. Phase I study of the combination of Sorafenib and Temsirolimus in patients with metastatic melanoma. Clin Cancer Res 18(4):1120-8, 2012. e-Pub 2012. PMID: 22223528.
Zhang HM, Perrier ND, Grubbs EG, Sircar K, Ye ZX, Lee JE, Ng CS. Computed tomography features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies. Clin Radiol 67(1):38-46, 2012. e-Pub 2012. PMID: 21783181.
Haygood TM, Malhotra K, Ng C, Chasen B, McEnery KW, Chasen M. Migration of central lines from the superior vena cava to the azygous vein. Clin Radiol 67(1):49-54, 2012. e-Pub 2012. PMID: 22070939.
Joseph RW, Sullivan RJ, Harrell R, Stemke-Hale K, Panka D, Manoukian G, Percy A, Bassett RL, Ng CS, Radvanyi L, Hwu P, Atkins MB, Davies MA. Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma. J Immunother 35(1):66-72, 2012. e-Pub 2012. PMID: 22130161.
Bronstein Y, Ng CS, Hwu P, Hwu WJ. Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy. AJR Am J Roentgenol 197(6):W992-W1000, 2011. e-Pub 2011. PMID: 22109345.
Matrana MR, Ng C, Rao P, Lim ZD, Tannir NM. Chromophobe renal cell carcinoma with sarcomatoid dedifferentiation treated with pazopanib: a case report. Clin Genitourin Cancer 9(2):137-9, 2011. e-Pub 2011. PMID: 21831725.
Coleman RL, Duska LR, Ramirez PT, Heymach JV, Kamat AA, Modesitt SC, Schmeler KM, Iyer RB, Garcia ME, Miller DL, Jackson EF, Ng CS, Kundra V, Jaffe R, Sood AK. Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol 12(12):1109-17, 2011. e-Pub 2011. PMID: 21992853.
Samuels J, Ng CS, Nates J, Price K, Finkel K, Salahudeen A, Shaw A. Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancer. Support Care Cancer 19(10):1527-32, 2011. e-Pub 2011. PMID: 20711842.
Tian M, Wen X, Jackson EF, Ng CS, Uthamanthil R, Liang D, Gelovani JG, Li C. Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study. Contrast Media Mol Imaging 6(4):289-97, 2011. e-Pub 2011. PMID: 21861289.
Kurzrock R, Sherman SI, Ball DW, Forastiere AA, Cohen RB, Mehra R, Pfister DG, Cohen EE, Janisch L, Nauling F, Hong DS, Ng CS, Ye L, Gagel RF, Frye J, Müller T, Ratain MJ, Salgia R. Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. J Clin Oncol 29(19):2660-6. e-Pub 2011.
Fu S, Naing A, Moulder SL, Culotta KS, Madoff DC, Ng CS, Madden TL, Falchook GS, Hong DS, Kurzrock R. Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel in cancer patients with predominant hepatic metastases: toxicity, pharmacokinetics, and activity. Mol Cancer Ther 10(7):1300-7, 2011. e-Pub 2011. PMID: 21571911.
Richey SL, Ng C, Lim ZD, Jonasch E, Tannir NM. Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapy. J Clin Oncol 29(8):e203-e205, 2011. e-Pub 2011. PMID: 21172884.
Tian M, Wen X, Jackson EF, Ng C, Uthamanthil R, Liang D, Gelovani JG, Li C. Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study. Contrast Media Mol Imaging 6(4):289-97, 2011. e-Pub 2011. PMID: 21213219.
Vaklavas C, Tsimberidou AM, Wen S, Hong D, Wheler J, Ng CS, Naing A, Uehara C, Wolff RA, Kurzrock R. Phase 1 clinical trials in 83 patients with pancreatic cancer: the M. D. Anderson Cancer Center experience. Cancer 117(1):77-85, 2011. e-Pub 2011. PMID: 20737567.
Ng CS, Chandler A, Wei W, Anderson EF, Herron DH, Charnsangavej C, Kurzrock R. Reproducibility of perfusion parameters obtained from perfusion computed tomography in lung tumors. AJR Am J Roentgenol 197(1):113-121, 2011. e-Pub 2011. PMID: 21701018.
Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND. Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience. J Am Coll Surg 212(4):659-665, 2011. e-Pub 2011. PMID: 21463807.
Chandler A, Wei W, Herron DH, Anderson EF, Johnson VE, Ng CS. Semiautomated motion correction of tumors in lung CT-perfusion studies. Acad Radiol 18(3):286-293, 2011. e-Pub 2011. PMID: 21295733.
Patnana M, Bronstein Y, Szklaruk J, Bedi D, Gershenwald JE, Hwu WJ, Prieto VG, Ng CS. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma. Clin Rad 66(3):224-236, 2011. e-Pub 2011. PMID: 21295201.
Ng CS, Chandler AG, Wei W, Herron DH, Anderson EF, Kurzrock R, Charnsangavej C. Reproducibility of computed tomography perfusion parameters in liver tumors and normal liver. Radiology 260(3):762-70, 2011. e-Pub 2011. PMID: 21788525.
Ng CS, Charnsangavej C, Wei W, Yao JC. Perfusion CT findings in patients with metastatic carcinoid tumors undergoing Bevacizumab and Interferon therapy. AJR Am J Roentgenol 196(3):569-576, 2011. e-Pub 2011. PMID: 21343498.
Naing A, Kurzrock R, Burger AM, Gupta S, Lei X, Busaidy NL, Hong DS, Chen HX, Doyle L, Heilbrun LK, Rohren E, Ng C, Chandhasin C, Lorusso PM. Phase I trial of Cixutumumab combined with Temsirolimus in patients with advanced cancer. Clin Cancer Res 17(18):6052-60, 2011. e-Pub 2011. PMID: 21750201.
Melancon MP, Lu W, Huang Q, Thapa P, Zhou D, Ng C, Li C. Targeted imaging of tumor-associated M2 Macrophages using a macromolecular contrast agent PG-Gd-NIR813. Biomaterials 31(25):6567-6573, 2010. e-Pub 2010. PMID: 20537382.
Ng CS, Shaw AD, Bell CS, Samuels JA. Effect of IV contrast medium on renal function in oncologic patients undergoing computed tomography in intensive care unit. AJR Am J Roentgenol 195(2):414-422, 2010. e-Pub 2010. PMID: 20651198.
Jonasch E, Corn P, Pagliaro LC, Warneke CL, Johnson MM, Tamboli P, Ng C, Aparicio A, Ashe RG, Wright JJ, Tannir NM. Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis. Cancer 116(1):57-65, 2010. e-Pub 2010. PMID: 19862815.
Ng CS, Palmer CR. Analysis of diagnostic confidence: application to data from a prospective randomized controlled trial of CT for acute abdominal pain. Acta Radiol 51(4):368-374, 2010. e-Pub 2010. PMID: 20350244.
Xu AD, Ng CS, Kamat A, Grossman HB, Dinney C, Sandler CM. Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms. AJR Am J Roentgenol 195(4):959-965, 2010. e-Pub 2010. PMID: 20858825.
Tsimberidou AM, Rudek MA, Hong D, Ng CS, Blair J, Goldsweig H, Kurzrock R. Phase 1 first-in-human clinical study of S-trans, trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors. Cancer Chemother Pharmacol 65(2):235-241, 2010. e-Pub 2010. PMID: 19484470.
Moulder S, Dhillon N, Ng C, Hong D, Wheler J, Naing A, Tse S, La Paglia A, Dorr R, Hersh E, Boytim M, Kurzrock R. A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer. Invest New Drugs 28(5):634-640, 2010. e-Pub 2010. PMID: 19499186.
Camacho LH, Garcia S, Panchal AM, Lim J, Hong DS, Ng C, Madoff DC, Fu S, Gayed I, Kurzrock R. Exploratory study of hepatic arterial infusion oxaliplatin with systemic 5-fluorouracil/bevacizumab in patients with refractory solid tumor and extensive liver metastases. Clin Colorectal Cancer 9(5):311-314, 2010. e-Pub 2010. PMID: 21208846.
Ravoori M, Czaplinska AJ, Sikes C, Han L, Johnson EM, Qiao W, Ng C, Cody DD, Murphy WA, Do KA, Navone NM, Kundra V. Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PLoS One 5(3):e9854, 2010. e-Pub 2010. PMID: 20360964.
Tsimberidou AM, Moulder S, Fu S, Wen S, Naing A, Bedikian AY, Daring S, Uehara C, Ng C, Wallace M, Camacho L, Kurzrock R. Phase I clinical trial of hepatic arterial infusion of Cisplatin in combination with intravenous liposomal Doxorubicin in patients with advanced cancer and dominant liver involvement. Cancer Chemother Pharmacol 66(6):1087-1093, 2010. e-Pub 2010. PMID: 20204368.
Tsimberidou AM, Fu S, Ng C, Lim JA, Wen S, Hong D, Wheler J, Bedikian AY, Eng C, Wallace M, Camacho LH, Kurzrock R. A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver. Cancer 116(17):4086-4094, 2010. e-Pub 2010. PMID: 20564148.
Ng CS, Wang X, Faria SC, Lin E, Charnsangavej C, Tannir NM. Perfusion computed tomography in patients with metastatic renal cell carcinoma treated with interferon. AJR Am J Roentgenol 194(1):166-171, 2010. e-Pub 2010. PMID: 20028919.
Ng CS, Raunig DL, Jackson EF, Ashton EA, Kelcz F, Kim KB, Kurzrock R, McShane TM. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses. AJR Am J Roentgenol 194(2):W134-W140, 2010. e-Pub 2010. PMID: 20093564.
Tsimberidou AM, Vaklavas C, Wen S, Hong D, Wheler J, Ng C, Naing A, Tse S, Busaidy N, Markman M, Sherman SI, Kurzrock R. Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experience. J Clin Endocrinol Metab 94(11):4423-4432, 2009. e-Pub 2009. PMID: 19820016.
Vikram R, Sandler CM, Ng CS. Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract. AJR Am J Roentgenol 192(6):1481-1487, 2009. e-Pub 2009. PMID: 19457808.
Vikram R, Sandler CM, Ng CS. Imaging and staging of transitional cell carcinoma: part 2, upper urinary tract. AJR Am J Roentgenol 192(6):1488-1493, 2009. e-Pub 2009. PMID: 19457809.
Kim KB, Hwu WJ, Papadopoulos NE, Bedikian AY, Camacho LH, Ng C, Hernandez IM, Frost AM, Jack MA, Hwu P. Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma. Cancer Chemother Pharmacol 64(1):161-167, 2009. e-Pub 2009. PMID: 19002462.
Hong DS, Sebti SM, Newman RA, Blaskovich MA, Ye L, Gagel RF, Moulder S, Wheler JJ, Naing A, Tannir NM, Ng CS, Sherman SI, El Naggar AK, Khan R, Trent J, Wright JJ, Kurzrock R. Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clin Cancer Res 15(22):7061-7068, 2009. e-Pub 2009. PMID: 19903778.
Tsimberidou AM, Camacho LH, Verstovsek S, Ng C, Hong DS, Uehara CK, Gutierrez C, Daring S, Stevens J, Komarnitsky PB, Schwartz B, Kurzrock R. A phase I clinical trial of Darinaparsin in patients with refractory solid tumors. Clin Cancer Res 15(14):4769-4776, 2009. e-Pub 2009. PMID: 19584162.
Vikram R, Ng CS, Tamboli P, Tannir NM, Jonasch E, Matin SF, Wood CG, Sandler CM. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics 29(3):741-754, 2009. e-Pub 2009. PMID: 19448113.
Ng CS, Kodama Y, Mullani NA, Barron BJ, Wei W, Herbst RS, Abbruzzese JL, Charnsangavej C. Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study. J Comput Assist Tomogr 33(3):460-465, 2009. e-Pub 2009. PMID: 19478644.
Beddar AS, Briere TM, Balter P, Pan T, Tolani N, Ng C, Szklaruk J, Krishnan S. 4D-computed tomography imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning. Radiother Oncol 87(3):445-448, 2008. e-Pub 2008. PMID: 18194819.
Ng CS, Palmer CR. Assessing diagnostic confidence: a comparative review of analytical methods. Acad Radiol 15(5):584-592, 2008. e-Pub 2008. PMID: 18423315.
See TC, Watson CJ, Arends MJ, Ng CS. Atypical appendicitis: the impact of computer tomography and its management. J Med Imaging Radiat Oncol 52(2):140-147, 2008. e-Pub 2008. PMID: 18373805.
Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Phase II trial of Curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14(14):4491-4499, 2008. e-Pub 2008. PMID: 18628464.
Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, Cormier JN, Gershenwald JE, Lee JE, Mansfield PF, Billings LA, Ng CS, Charnsangavej C, Bar-Eli M, Johnson MM, Murgo AJ, Prieto VG. Phase II trial of Imatinib Mesylate in patients with metastatic melanoma. Brit J Cancer 99(5):734-740, 2008. e-Pub 2008. PMID: 18728664.
Osai WE, Ng CS, Pagliaro LC. Positive response to bevacizumab in a patient with metastatic, chemotherapy-refractory urothelial carcinoma. Anticancer Drugs 19(4):427-429, 2008. e-Pub 2008. PMID: 18454053.
Yao JC, Phan A, Hoff PM, Chen HX, Charnsangavej C, Yeung SC, Hess K, Ng C, Abbruzzese JL, Ajani JA. Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol 26(8):1316-1323, 2008. e-Pub 2008. PMID: 18323556.
Ashton E, Raunig D, Ng C, Kelcz F, McShane T, Evelhoch J. Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. J Magn Reson Imaging 28(3):791-796, 2008. e-Pub 2008. PMID: 18777526.
Ng CS, Wei W, Doyle TC, Courtney HM, Dixon AK, Freeman AH. Minimal-preparation abdomino-pelvic computed tomography in frail and elderly patients: prognostic value of colonic and extracolonic findings. Clin Radiol 63(4):424-432, 2008. e-Pub 2008. PMID: 18325363.
Tannir NM, Thall PF, Ng CS, Wang X, Wooten L, Siefker-Radtke A, Mathew P, Pagliaro L, Wood C, Jonasch E. A phase II trial of Gemcitabine plus Capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents. J Urol 180(3):867-72; discussion 872, 2008. e-Pub 2008. PMID: 18635226.
Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CM. Renal cell carcinoma: diagnosis, staging and surveillance. AJR Am J Roentgenol 191(4):1220-1232, 2008. e-Pub 2008. PMID: 18806169.
Krishnan S, Briere TM, Dong L, Murthy R, Ng CS, Balter P, Mohan R, Gillin MT, Beddar AS. Daily targeting of liver tumors: screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy. Med Phys 34(12):4591-3, 2007. e-Pub 2007. PMID: 18196785.
Faria SC, Ng CS, Hess KR, Phongkitkarun S, Herron DH, Szejnfeld J, Daliani D, Charnsangavej C. Computed tomography quantification of effects of Thalidomide in patients with metastatic renal cell carcinoma. AJR Am J Roentgenol 189(2):378-385, 2007. e-Pub 2007. PMID: 17646464.
Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with Imatinib. Ann Surg Oncol 14(1):14-24, 2007. e-Pub 2007. PMID: 17072676.
Kundra V, Ng CS, Ma J, Bankson JA, Price RE, Cody DD, Do KA, Han L, Navone NM. In vivo imaging of prostate cancer involving bone in a mouse model. Prostate 1(67):50-60, 2007. e-Pub 2007. PMID: 17031813.
Rosen LS, Kurzrock R, Mulay M, Van Vugt A, Purdom M, Ng C, Silverman J, Koutsoukos A, Sun YN, Bass MB, Xu RY, Polverino A, Wiezorek JS, Chang DD, Benjamin R, Herbst RS. Safety, pharmacokinetics, and efficacy of AMG 706, an investigational, oral, multikinase inhibitor in patients with advanced solid tumors. J Clin Oncol 25(17):2369-2376, 2007. e-Pub 2007. PMID: 17557949.
Gonzalez RJ, Tamm EP, Ng C, Phan AT, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. Surgery 142(6):867-875, 2007. e-Pub 2007. PMID: 18063070.
Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C. Comparison of CT methods for determining fat content of the liver. AJR Am J Roentgenol 188(5):1307-1312, 2007. e-Pub 2007. PMID: 17449775.
Ng CS, Palmer CR. Analysis of diagnostic confidence and diagnostic accuracy: a unified framework. Br J Radiol 80(951):152-160, 2007. e-Pub 2007. PMID: 17329682.
Jackson EF, Esparza-Coss E, Wen X, Ng CS, Daniel SL, Price RE, Rivera B, Charnsangavej C, Gelovani JG, Li C. Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids. Int J Radiat Oncol Biol Phys 68(3):830-838, 2007. e-Pub 2007. PMID: 17379450.
Krishnan S, Briere TM Dong L, Murthy R, Ng CS, Balter P, Mohan R, Gillin MT, Beddar AS. Daily targeting of liver tumors: screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy. Med Phys 34(12):4591-4593, 2007. e-Pub 2007. PMID: 17646464.
Aloia TA, Gershenwald JE, Andtbacka RH, Johnson MM, Schacherer CW, Ng CS, Cormier JN, Lee JE, Ross MI, Mansfield PF. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. J Clin Oncol 24(18):2858-2865, 2006. e-Pub 2006. PMID: 16782925.
Ng CS. Radiologic diagnosis and staging of renal and bladder cancer. Semin Roentgenol 41(2):121-138, 2006. e-Pub 2006. PMID: 16697891.
Madoff DC, Abdalla EK, Wallace MJ, Ng CS, Ribero D, Vauthey JN. Portal vein embolization: a preoperative approach to improve the safety of major hepatic resection. Curr Med Imaging Rev 2(4):385-404, 2006. e-Pub 2006.
Braiteh F, Ng C, Kurzrock R. Refractory Hodgkin lymphoma responds to pentostatin (2'-deoxycoformycin). Leuk Lymphoma 47(2):373-375, 2006. e-Pub 2006. PMID: 16321875.
Tannir NM, Cohen L, Wang X, Thall P, Mathew PF, Jonasch E, Siefker-Radtke A, Pagliaro LC, Ng CS, Logothetis C. Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma. Cancer 107(9):2254-2261, 2006. e-Pub 2006. PMID: 17029276.
Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng CS, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol 24(7):1145-1151, 2006. e-Pub 2006. PMID: 16505434.
Liu G, Rugo H, Wilding G, McShane T, Evelhoch J, Ng C, Jackson E, Kelcz F, Yeh B, Lee Jr F, Charnsangavej C, Park J, Ashton E, Steinfeldt H, Pithavala Y, Reich S, Herbst R. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing a AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. J Clin Oncol 23(24):5417-5419, 2005. e-Pub 2005. PMID: 16027440.
Kazama T, Ng CS, Giralt SA. Multiphasic computed tomography and magnetic resonance imaging appearances of extramedullary multiple myeloma involving the stomach, pancreas, and bladder. Clin Imaging 29(4):263-265, 2005. e-Pub 2005. PMID: 15967318.
See TC, Davies SE, Appleton, DS, Ng CS. Computed tomography and angiographic features of hepatic inflammatory myofibroblastic tumor. Clin Radiol 60(6):718-722, 2005. e-Pub 2005. PMID: 16038700.
Ng CS, Freeman AH. Incidental lesions found on CT colonography: their nature and frequency. Br J Radiol 78(925):20-21, 2005. e-Pub 2005. PMID: 15673524.
Leibovici D, Kamat AM, Do KA, Pettaway CA, Ng CS, Evans RB, Rodriguez-Bigas M, Skibber J, Wang X, Pisters LL. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer. Prostate 62(1):101-104, 2005. e-Pub 2005. PMID: 15389800.
Guillerman RP, Ng CS. Ultrasound of appendicitis. Ultrasound 13(2):78-85, 2005. e-Pub 2005.
Bernal R, Freeman AH, Ng CS. Computed tomography in the acute abdomen. CME Radiology 4(3):92-95, 2004. e-Pub 2004.
Ng CS, Doyle TC, Courtney HM, Campbell GA, Freeman AH, Dixon AK. Extracolonic findings in patients undergoing abdomino-pelvic CT for suspected colorectal carcinoma in the frail and disabled patient. Clin Radiol 59(5):421-430, 2004. e-Pub 2004. PMID: 15081847.
Izzo F, Marra P, Beneduce G, Castello G, Vallone P, De Rosa V, Cremona F, Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA, Ng C, Curley SA. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. J Clin Oncol 22(10):1815-1822, 2004. e-Pub 2004. PMID: 15143074.
Kobayashi S, Ng CS, Kazama T, Madoff DC, Faria SC, Vauthey JN, Charnsangavej C. Hemodynamic and morphologic changes after portal vein embolization: differential effects in central and peripheral zones in the liver on multiphasic computed tomography. J Comput Assist Tomogr 28(6):804-810, 2004. e-Pub 2004. PMID: 15538155.
O'Donohue J, Ng CS, Catnach SM, Farrant P, Williams R. Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease. Eur J of Gastroenterol Hepatol 16(2):147-155, 2004. e-Pub 2004. PMID: 15075987.
See TC, Athey PA, Ng CS. Computed tomography and ultrasound appearances of appendicitis on ultrasonography and computed tomography. Radiology Now 21(1):15-19, 2004. e-Pub 2004.
Scaife CL, Ng CS, Ellis LM, Vauthey JN, Charnsangavej C, Curley SA. Accuracy of preoperative imaging of hepatic tumors with helical computed tomography. Ann Surg Oncol 10(5_suppl):S29-S30, 2003. e-Pub 2003.
Markose G, Ng CS, Freeman AH. The impact of helical computed tomography on the diagnosis of unsuspected inflammatory bowel disease in the large bowel. Eur Radiol 13(1):107-113, 2003. e-Pub 2003. PMID: 12541117.
Ford MB, Sigurdson AJ, Petrulis ES, Ng CS, Kemp B, Cooksley C, McNeese M, Selwyn BJ, Spitz MR, Bondy ML. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer 98(7):1457-1464, 2003. e-Pub 2003. PMID: 14508833.
Ng CS, Doyle TC, Dixon AK, Miller R, Arends MJ. Histopathological correlates of abnormal pericolic fat on computed tomography in the assessment of colorectal carcinoma. Br J Radiol 75(889):31-37, 2002. e-Pub 2002. PMID: 11806956.
Ng CS, Doyle TC, Pinto EM, Courtney HM, Bull RK, Prevost AT, Campbell GA, Freeman AH, Dixon AK. Evaluation of computed tomography in identifying colorectal carcinoma in the frail and disabled patient. Eur Radiol 12(12):2988-2997, 2002. e-Pub 2002. PMID: 12439581.
Ng CS, Watson CJ, Palmer CR, See TC, Beharry NA, Housden BA, Bradley JA, Dixon AK. Evaluation of early abdomino-pelvic computed tomography in patients with acute abdominal pain of unknown cause: prospective randomised study. BMJ 325(7377):1387, 2002. e-Pub 2002. PMID: 12480851.
Ng CS, Doyle TC, Pinto EM, Courtney HM, Miller R, Bull RK, Freeman AH, Dixon AK. Caecal carcinomas in the elderly: useful signs in minimal preparation computed tomography. Clin Radiol 57(5):359-364, 2002. e-Pub 2002. PMID: 12014932.
Evans JW, Dutton J, Ng C, Arends M. Calcified "Sister Mary Joseph" umbilical metastasis from ovarian cystadenocarcinoma seen on an MDP bone scintigram. Clin Nucl Med 27(2):134-135, 2002. e-Pub 2002. PMID: 11786748.
See TC, Ng CS, Watson CJ, Dixon AK. Appendicitis: spectrum of appearances on helical computed tomography. Br J Radiol 75(897):775-781, 2002. e-Pub 2002. PMID: 12200249.
Ng CS, Gishen P. Bone biopsies. Imaging 12(3):171-177, 2000. e-Pub 2000.
Ng CS, Gishen P. Picture quiz. Imaging 12(3):235-239, 2000. e-Pub 2000.
Ng CS, Loyer EM, Iyer RB, David CL, DuBrow RA, Charnsangavej C. Metastases to the pancreas from renal cell carcinoma: findings on three-phase contrast-enhanced helical computed tomography. AJR Am J Roentgenol 172(6):1555-1559, 1999. e-Pub 1999. PMID: 10350288.
Ng CS, Munden RF, Libshitz HI. Malignant pleural mesothelioma: the spectrum of manifestations on computed tomography in 70 cases. Clin Radiol 54(7):415-421, 1999. e-Pub 1999. PMID: 10437690.
Ng CS, Desai SR, Rubens MB, Padley SP, Wells AU, Hansell DM. Visual quantitation and observer variation of signs of small airways disease at inspiratory and expiratory computed tomography. J Thorac Imaging 14(4):279-285, 1999. e-Pub 1999. PMID: 10524809.
Ng CS, Wells AU, Padley SP. A computed tomography sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 14(4):270-278, 1999. e-Pub 1999. PMID: 10524808.
Ng CS, Hall CM. Costochondral junction fractures and intra-abdominal trauma in non-accidental injury (child abuse). Pediatr Radiol 28(9):671-676, 1998. e-Pub 1998. PMID: 9732490.
Ng CS, Salisbury JR, Darby AJ, Gishen P. Radiologically guided bone biopsy: results of 502 biopsies. Cardiovasc Intervent Radiol 21(2):122-128, 1998. e-Pub 1998. PMID: 9502678.
Ng CS, Husband JE, MacVicar AD, Ross P, Cunningham DC. Correlation of computed tomography with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapy. Clin Radiol 53(6):422-427, 1998. e-Pub 1998. PMID: 9651057.
Ng CS, de Bruyn R, Gordon I. The investigation of renovascular hypertension in children: the accuracy of radio-isotopes in detecting renovascular disease. Nucl Med Commun 18(11):1017-1028, 1997. e-Pub 1997. PMID: 9423201.
Bees NR, Ng CS, Dicks-Mireaux C, Kiely EM. Gastric malignant schwannoma in a child. Br J Radiol 70(837):952-955, 1997. e-Pub 1997. PMID: 9486074.
Ng CS, Husband JE, Padhani AR, Long MA, Horwich A, Hendry WF, Dearnaley DP. Evaluation by magnetic resonance imaging of the inferior vena cava in patients with non-seminomatous germ cell tumours of the testis metastatic to the retroperitoneum. Br J Urol 79(6):942-951, 1997. e-Pub 1997. PMID: 9202564.
Ng CS, Hall CM, Shaw DG. The range of visceral manifestations of non-accidental injury. Arch Dis Child 77(2):167-174, 1997. e-Pub 1997. PMID: 9301362.
Wilcox DT, Quinn FM, Ng CS, Dicks-Mireaux C, Mouriquand PD. Redefining the genital abnormality in the Robinow syndrome. J Urol 157(6):2312-2314, 1997. e-Pub 1997. PMID: 9146662.
Ng CS, Taylor CB, O'Donnell PJ, Pozniak AL, Michell MJ. Case report: mammographic and ultrasound appearances of Kaposi's sarcoma of the breast. Clin Radiol 51(10):735-736, 1996. e-Pub 1996. PMID: 8893647.
Clemente-Gutierrez U, Pieterman CRC, Lui MS, Yamashita TS, Huang BL, Shirali AS, Erstand DJ, Lee JE, Fisher SB, Graham PH, Grubbs EG, Waguespack S, Ng CS, and Perrier ND. Beyond the 3 P’s: Adrenal involvement in MEN1. Endocrine-Related Cancer.

Invited Articles

Tamm EP, Kim EE, Ng CS. Imaging of neuroendocrine tumors. Hematol Oncol Clin North Am 21(3):409-432, 2007. e-Pub 2007. PMID: 17548032.
Ng CS, Fenstermacher MJ, Silverman PM. Multislice CT in 3D imaging for partial nephrectomy. CT Update (Amersham Health) 3:3-4, 2003. e-Pub 2003.

Review Articles

Katabathina VS, Lassau N, Pedrosa I, Ng CS, Prasad SR. Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging. Curr Urol Rep 13(1):70-81, 2012. e-Pub 2012. PMID: 22143974.
Ashcroft MW, Ng CS, Frost RA, Freeman AH. Biliary inflammatory pseudotumour: report of two cases and review of the literature. Clin Radiol 64(4):449-455, 2009. e-Pub 2009. PMID: 19264191.
Koo BC, Ng CS, J U-King-Im J, Prevost AT, Freeman AH. Minimal preparation computed tomography for the diagnosis of suspected colorectal cancer in the frail and elderly patient. Clin Radiol 61(2):127-139, 2006. e-Pub 2006. PMID: 16439217.
Bedi DG, Gombos DS, Ng CS, Singh S. Sonography of the eye. AJR Am J Roentgenol 187(4):1061-1072, 2006. e-Pub 2006. PMID: 16985158.
Ng CS. The role of imaging in the management of primary pleural malignancies. Cancer Imaging 3:139-145, 2003. e-Pub 2003.
Turner DR, Markose G, Arends MJ, Ng CS, Freeman AH. Unusual causes of colonic wall thickening on computed tomography. Clin Radiol 58(3):191-200, 2003. e-Pub 2003. PMID: 12639525.

Professional Educational Materials

Charnsangavej C, Choi H, Jackson E, Ng C. Functional imaging for monitoring targeted therapy in solid tumors. In: Advances in Oncology Grand Rounds. The University of Texas MD Anderson Cancer Center, UT Television, 2004.

Abstracts

Ahmed J, Stephen B, Beyaz S, Chung C, Kilic E, Khawaja MR, Yang Y, Raso GG, Karp DD, Piha-Paul SA, Sood A, Ng C, Johnson AM, Soliman PT, Meric-Bernstam F, Lu KH, Naing A. A Phase 1 Dose Escalation Study of Temsirolimus in Combination with Metformin in Patients with Advanced Endometrial Cancers, 2023. e-Pub 2023.
Loyer, Kang EM, HC Ng C. Detection of Pancreatic Adenocarcinoma in 2022 : DECT or High Resolution MDCT, 2023. e-Pub 2023.
Loyer EM, Kang HC, Ng CS. Detection of Pancreatic Adenocarcinoma in 2022 : DECT or High Resolution MDCT. Society of Abdominal Radiology (SAR), 2023. e-Pub 2023.
Clemente-Gutierrez U, Pieterman CRC, Erstad DJ, Lui MS, Huang BL, Shirali AS, Fisher SB, Graham PH, Grubbs EG, Waguespack SG, Ng CS, Perrier NA. Beyond the 3 P’s: Adrenal Involvement in MEN1. 18th International Workshop on Multiple Endocrine Neoplasia and Other Rare Endocrine Tumors 2023, 2023. e-Pub 2023.
Clemente-Gutierrez U, Pieterman CRC, Erstad DJ, Lui MS, Huang BL, Shirali AS, Fisher SB, Graham PH, Grubbs EG, Waguespack SG, Ng CS, Perrier NA. Beyond the 3 P’s: Adrenal Involvement in MEN1. Society of Surgical Oncology and Advanced Cancer Therapies, 2022. e-Pub 2022.
McCullough P, Ng C, Ryan M, Baker E, Mehta R. Contrast media and MACE or renal events in high-risk patients undergoing intra-arterial procedures. Cardiorenal Connections Conference. e-Pub 2021.
Gao J, Karam JA, Tannir N, Campbell M, Tidwell R, Ahrar K, Rao P, Ng C, Jonasch E, Matin S, Zurita A, Shah A, Shen Y, Blando J, Vence L, Basu S, Zhao H, Allison J, Wood C, Sharma P. A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eligible for cytoreductive nephrectomy, metastasectomy or post-treatment biopsy (Bx). American Society of Clinical Oncology 55th Annual Meeting 37(15_suppl), 2019. e-Pub 2019.
Zagzag J, Perrier ND, Graham PH, Grubbs EG, Lee JE, Ng CS, Elsayes KM, Jimenez C. Rates of adrenal pathology in MEN1. Western Surgical Association 126th Scientific Session 2018 Annual Meeting. e-Pub 2018.
Ng CS, Kalva S, Gunnarsson C, Ryan MP, Baker ER, Dunham DM, Rangwala NA, Mehta R. Renal events following intravenous iodinated contrast media administration among inpatients admitted with cancer. International Cancer Imaging Society (ICIS) Meeting and 18th Annual Teaching Course 18(1_suppl). e-Pub 2018.
Gao J, Karam JA, Tannir NM, Slack R, Ahrar K, Rao P, Ng CS, Jonasch E, Campbell MT, Matin SF, Zurita AJ, Wang J, Blando JM, Zhao H, Vence LM, Basu S, Chen H, Allison JP, Wood CG, Sharma P. A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eligible for cytoreductive nephrectomy (CN), metastasectomy (MS) or post-treatment biopsy (Bx). American Society of Clinical Oncology (ASCO) 54th Annual Meeting 36(15_suppl), 2018. e-Pub 2018.
Petros F, Venkatesan A, Kaya D, Ng CS, Fellman B, Karam J, Wood C, Matin S. Conditional survival and landmark analysis for patients with small renal masses undergoing active surveillance at a tertiary care center. 2018 Genitourinary Cancers Symposium of the American Society of Clinical Oncology 199(4_suppl):e976, 2018. e-Pub 2018.
Petros FG, Petros FG, Venkatesan AM, Venkatesan AM, Kaya D, Kaya D, Ng CS, Ng CS, Fellman BM, Fellman BM, Karam JA, Karam JA. Conditional survival and landmark analysis for patients with small renal masses undergoing active surveillance at a tertiary care center. American Society of Clinical Oncology 2018 Genitourinary Cancers Symposium 36(6_suppl), 2018. e-Pub 2018.
McCormick B, Meissner M, Fellman B, Petros F, Venkatesan A, Kaya D, Ng C, Karam J, Wood C, Matin S. Frailty index is a more comprehensive predictor of survival outcomes in patients with small renal masses on active surveillance than conventional parameters. American Urological Association 2018 Annual Meeting, 2018. e-Pub 2018.
Lee TY, Su F, Ng CS, Lee SI, Burgers K, Zheng Z, Coleman RL, Bookman M. Reproducibility of computed tomography perfusion in ovarian cancer- a substudy of ACRIN 6695/GOG-0262. 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America 48. e-Pub 2017.
Petros FG, Venkatesan AM, Kaya D, Ng CS, Fellman BM, Karam JA, Wood CG, Matin SF. Conditional Survival and Landmark Analysis for Patients with Small Renal Cell Carcinoma Undergoing Active Surveillance at a Tertiary Care Center. 18th Annual Meeting of the Society of Urologic Oncology:48. e-Pub 2017.
Naing A, Lopez-Berestein G, Fu S, Tsimberidou AM, Pant S, Piha-Paul SA, Janku F, Hong DS, Sulovic S, Meng X, Jazaeri AA, Ng CS, Karp DD, Subbiah V, Meric-Bernstam F, Mitra R, Wu S, Sood AK, Coleman RL. EphA2 gene targeting using neutral liposomal small interfering RNA (EPHARNA) delivery: A phase I clinical trial. American Society of Clinical Oncology (ASCO) 53rd Annual Meeting 35(15_suppl). e-Pub 2017.
Gao J, Karam JA, Wood CG, Matin S, Ahrar K, Jonasch E, Tannir NM, Campbell M, Ng CS, Slack R, Rao P, Allison JP, Blando JM, Vence LM, Basu S, Zhao H, Chen T, Chen H, Sharma P. Clinical activity, immune and molecular correlates of nivolumab vs. nivolumab plus bevacizumab vs nivolumab plus ipilimumab in metastatic renal cell carcinoma. American Association for Cancer Research (AACR) Annual Meeting 77(13):ct083. e-Pub 2017.
Robert-Edan V, Lakhal K, Quartin A, Hobbs B, Cely C, Bell C, Pham T, Schein R, Geng Y, Ng CS, Ehrmann S. Contrast-associated acute kidney injury (AKI) in the intensive care unit (ICU): Systematic review and meta-analysis. Réanimation 2017, Annual Congress of the French Intensive Care Society 43. e-Pub 2017.
Lee TY, Burgers K, Ng CS, Zhang Z, Coleman R, Mannel R, Rosen MA, Lee SI. Effective radiation dose of perfusion CT exams of ovarian cancer patients: a multi-center study. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America. e-Pub 2016.
Voss RK, Kim BJ, Loyer EM, Day RW, Ng CS, Vauthey JN, Aloia TA. CT imaging does not increase the risk of second malignancy in patients with colorectal liver metastases. Western Surgical Association 124th Scientific Session 2016 Annual Meeting:p107, 2016. e-Pub 2016.
Ghosh P, Chandler A, Altinmakas E, Rong XJ, Janku F, Ng CS. Quantitative assessment of motion occurring during shuttle mode computed tomography (CT) acquisitions for body perfusion imaging applications. Radiological Society of North America (RSNA) 100th Scientific Assembly and Annual Meeting, 2016. e-Pub 2014.
Khawaja MR, Madhusudanannair V, Ng CS, Nick A, Janku F, Piha-Paul S, Coleman R, Soliman P, Fu S, Hong D, Karp D, Subbiah V, Tsimberidou A, Meric-Bernstam F, Lu K, Naing A. Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced cancers. American Association for Cancer Research 14(12_Suppl 2):C44, 2016. e-Pub 2016.
Khawaja MR, Madhusudanannair V, Ng C, Nick A, Janku F, Piha-Paul S, Coleman R, Soliman P, Fu S, Hong D, Karp D, Subbiah V, Tsimberidou A, Meric-Bernstam F, Lu K, Naing A. Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced cancers. Abstract AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 14(12_Suppl):c44. e-Pub 2015.
Lee T, Ng CS, Lee S, Rosen M, Su F, Bauza J, Zhang Z, Edwards S, Weber T. Quality Assurance in a Multicenter Trial Evaluating Quantitative CT Perfusion Imaging as a Biomarker of Patient Outcome in Ovarian Cancer Chemotherapy: An ECOG-ACRIN and NRG GOG Study. Radiological Society of North America 101st Scientific Assembly and Annual Meeting, 2015. e-Pub 2015.
Phan AT, Halperin DM, Chan JA, Fogelman DR, Hess KR, Malinowski P, Regan E, Ng CS, Yao JC, Kulke MH. A prospective, multi-institutional phase II study of pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumors. North American Neuroendocrine Tumor Society (NANETS) 8th Annual Symposium 44(2):356. e-Pub 2015.
Lee TY, Ng CS, Zhang Z, Lee S, Marques H, Burgers K, Su F, Bauza J, Mannel RS, Walker JL, Huh WK, Rubin SC, DiSilvestro P, Martin LP, Chan JK, Bookman MA, Coleman RL. CT perfusion as an early biomarker of treatment efficacy in advanced ovarian cancer: An ECOG-ACRIN and NRG GOG study. American Society of Clinical Oncology (ASCO) Annual Meeting / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer 33(15_suppl). e-Pub 2015.
Popnoe D, Zhou S, Ng CS, Loyer E, Kang H, Kaur H, Jones A. Feasibility of using virtual unenhanced images to replace true unenhanced images in multiphase renal CT exams. American Association of Physicists in Medicine (AAPM) Spring Clinical Meeting 2015 16(3):441. e-Pub 2015.
Ghosh P, Chandler A, Altinmakas E, Rong XJ, Janku F, Ng CS. Quantitative assessment of motion occurring during shuttle mode computed tomography (CT) acquisitions for body perfusion imaging applications. Society of Photo-optical Instrumentation Engineers Medical Imaging:42. e-Pub 2015.
Faria S, Sagebiel T, Rao B, Gupta S, Devine C, Patnana M, Ng CS, Bhosale P. Metastatic melanoma: pictorial review of the usual and unusual faces of this serious tumor. Radiological Society of North America (RSNA) 100th Scientific Assembly and Annual Meeting, 2014. e-Pub 2014.
Hunter L, Yang J, Fried I, Rao A, Tucker S, Stingo F, Lin SH, Ng C, Liao Z, Court L. IBEX: an open software infrastructure platform to accelerate collaborative work on quantitative image features and predictive models. American Association of Physicists in Medicine (AAPM) 2014 Innovation 56th Annual Meeting & Exhibition. e-Pub 2014.
Tannir NM, Jonasch E, Altinmakas E, Ng CS, Qiao W, Tamboli P, Rao P, McDermott DF, Wood CG, Choueiri TK. Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (The ESPN Trial): a multicenter randomized phase 2 trial. American Society of Clinical Oncology 50th Annual Meeting 32(15_Suppl), 2014. e-Pub 2014.
Duran C, Ng C. Perfusion CT: an early marker in the assessment of tumor response to antiangiogenic drugs. 99th Radiological Society of North America Annual Meeting 189(45):E535. e-Pub 2013.
Bednarski BK, Habra M, Phan A, Evans DB, Katz MH, Ng C, Perrier N D, Lee JE, Grubbs EG. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. International Association of Endocrine Surgeons (IAES) Annual Meeting 2013 445. e-Pub 2013.
Court L, Yang J, Hunter L, Ng CS. Understanding uncertainties in quantitative image features extracted from contrast-enhanced CT images. American Association of Physicists in Medicine 55th Annual Meeting & Exhibition 40(6):138. e-Pub 2013.
Court L, Yang J, Hunter L, Ng CS. Understanding uncertainties in quantitative features extracted from contrast-enhanced CT images. American Association of Physicists in Medicine 55th Annual Meeting & Exhibition 40(6):138. e-Pub 2013.
Cauley DH, Atkinson BJ, Ng C, Millikan RE, Xiao L, Corn PG, Jonasch E, Tannir NM. mTOR inhibitor-associated noninfectious pneumonitis in patients with metastatic renal cell cancer: a single-center experience. American Society of Clinical Oncology 48th Annual Meeting 31(15_suppl):376-382, 2013. e-Pub 2013.
Parker PA, Alba F, Fellman B, Urbauer BL, Li Y, Ng CS, Karam JA, Tannir NM, Jonasch E, Wood CG, Martin SF. Role of Uncertainty on Quality of Life (QOL) in Patients with Localized Renal Tumors on Active Surveillance (AS): A Prospective 2-Year Study 189(4_suppl):e535, 2013. e-Pub 2013.
Tannir NM, Plimack ER, Ng CS, Tamboli P, Bekele BN, Xiao L, Smith LA, Lim ZD, Pagliaro LC, Araujo JC, Aparicio A, Matin SF, Wood CG, Jonasch E. A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma. e-Pub 2012.
Duran C, Ganeshan D, Yao J, Phan A, Ng CS, Loyer E, Charnsangavej C. Spectrum of hepatic metastases from neuroendocrine tumors (NETs) and pitfalls of the detection and measurements of the lesions. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America:[LL-GIE4061]. e-Pub 2012.
Cauley DH, Atkinson BJ, Ng CS, Wang XM, Xiao LC, Corn PG, Jonasch E, Tannir NM. Everolimus (E) and temsirolimus (T) associated pneumonitis (P) in patients with metastatic renal cell cancer (mRCC): A single-center experience. American Society of Clinical Oncology 48th Annual Meeting 30(5_suppl), 2012. e-Pub 2012.
Ng C, Lee T, Coleman R, Zhang Z, Dunnington B, L'Heureux D, Mannel R, Lee S. ACRIN 6695 perfusion computed tomography as prognostic imaging biomarker in ovarian cancer. American Society of Clinical Oncology 48th Annual Meeting 30(15_suppl). e-Pub 2012.
Katabathina C, Vikram R, Pedrosa I, Lassau N, Ng C, Shah SN, Prasad S. Measuring response to targeted therapies in metastatic renal cell carcinoma: current concepts & future directions. Abdominal Radiology Course, 2012. e-Pub 2012.
Kurzrock R, Sherman SI, Ball DW, Forastiere AA, Cohen RB, Mehra R, Pfister DG, Cohen EEW, Janisch L, Nauling F, Hong DS, Ng CS, Ye L, Gagel RF, Frye J, Muller T, Ratain MJ, Salgia R. Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. 14th International Thyroid Congress 29(19):2660-6. e-Pub 2011. PMID: 21606412.
Jakob JA, Bassett Jr RL, Ng CS, Lazar AJF, Alvarado GC, Rohlfs ML, Richard J, Gershenwald GE, Hwu P, Kim KB, Davies MA. Clinical characteristics and outcomes associated with BRAF and NRAS mutations in metastatic melanoma. American Society of Clinical Oncology 47th Annual Meeting 29(15_suppl). e-Pub 2011.
Dickstein RJ, Ng C, Dinney CP, Kamat A. A blinded study to assess the accuracy of computerized tomography in staging patients with muscle-invasive bladder cancer. American Urological Association Annual Meeting 2011, 2011. e-Pub 2011.
Cauley D, Atkinson B, Ng C, Corn P, Jonasch E, Tannir N. Everolimus-associated pneumonitis (EAP) in metastatic renal cell cancer patients (mRCC): a single-center experience. Meeting Abstract: 2012 Genitourinary Cancers Symposium 29(7_suppl). e-Pub 2011.
Meng ZQ, Liu LM, Yang P, Cohen L, Huo Y, Zhao Q, Spelman AR, Ng C, Chang DZ, Garrett CR. A randomized phase II study of gemcitabine (G) plus the cardiac glycoside huachansu (H) in the treatment of patients with locally advanced (LAPC) or metastatic pancreatic cancer (MPC). American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 29(4_suppl), 2011. e-Pub 2011.
Yao JC, Phan A, Hess KR, Fogelman D, Jacobs C, Dagohoy CG, Leary CC, Ng CS. Randomized run-in study of bevacizumab and everolimus in low- to intermediate-grade neuroendocrine tumors (LGNETs) using perfusion CT (pCT) as functional biomarker. North American Neuroendocrine Tumor Society 3rd Annual Meeting 40(2):335-336. e-Pub 2010.
Melancon MP, Lu W, Eliott A, Taylor BA, Huang Q, Hazle JD, Ng C, Li C, Stafford RJ. MRI-guided thermal ablation using multimodality, multifunctional SPIO@Au nanoshell targeted to epidermal growth factor receptors. World Molecular Imaging Congress:Presentation Number 0502B. e-Pub 2010.
Kurzrock R, Sherman SI, Ball DW, Forastiere AA, Cohen RB, Mehra R, Pfister DG, Cohen EEW, Janisch L, Nauling F, Hong DS, Ng CS, Ye L, Gagel RF, Frye J, Muller T, Ratain MJ, Salgia R. Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. 14th International Thyroid Congress 70(8 suppl):2753. e-Pub 2010.
Phan, AT, Yao JC, Fogelman DR, Hess KR, Ng CS, Bullock SA, Malinowski P, Regan E, Kulke M. A prospective, multi-institutional phase II study of GW786034 (pozopanib) and depot octreotide (sandostatin LAR) in advanced low-grade neuroendocrine carcinoma (LGNEC). American Society of Clinical Oncology 46th Annual Meeting 28(15_suppl). e-Pub 2010.
Plimack ER, Jonasch E, Bekele BN, Qiao W, Ng C, Tannir NM. Sunitinib in papillary renal cell carcinoma (pRCC): results from a single-arm phase II study. American Society of Clinical Oncology Annual Meeting 28(15_suppl). e-Pub 2010.
Falchook GS, Wheler JJ, Naing A, Hong DS, Moulder SL, Piha-Paul SA, Ng CS, Jackson E, Kurzrock R. A phase I study of bevacizumab in combination with sunitinib, sorafenib, erlotinib plus cetuximab, and trastuzumab plus lapatinib. American Society of Clinical Oncology Annual Meeting 28(15_suppl). e-Pub 2010.
Yao JC, Phan AT, Fogleman D, Ng CS, Jacobs CB, Dagohoy CG, Leary C, Hess KR. Randomized run-in study of bevacizumab (B) and everolimus (E) in low- to intermediate- grade neuroendocrine tumors (LGNETs) using perfusion CT as functional biomarker. Journal of Neuroendocrine Tumors and Pancreatic Diseases and Sciences 28(15_suppl), 2010. e-Pub 2010.
Phan AT, Yao JC, Fogelman DR, Hess KR, Ng CS, Bullock SA, Malinowski P, Regan E, Kulke M. A prospective, multi-institutional phase II study of GW786034 (pazopanib) and depot octreotide (sandostatin LAR) in advanced low-grade neuroendocrine carcinoma (LGNEC). Meeting Abstract: 2010 ASCO Annual Meeting I 28(15_suppl). e-Pub 2010.
Fu S, Naing A, Moulder SL, Falchook GS, Culotta KS, Zhang Y, Madoff DC, Ng CS, Lim J, Kurzrock R. A phase I study of hepatic arterial infusion of nab-paclitaxel in patients with predominant hepatic metastases. ASCO Annual Meeting I 28(15_suppl), 2010. e-Pub 2010.
Patnana M, Vikram R, Ng C, Sandler C. Clear cell renal cell carcinoma: MDCT and magnetic resonance imaging appearances. 110th Annual Meeting of the American Roentgen Ray Society 194(5_suppl):a210. e-Pub 2010.
Jain RK, Lee JJ, Ng CS, Hong D, Gong J, Naing A, Jane J, Kurzrock R. Change in tumor size by RECIST correlates linearly with progression-free and overall survival in phase I studies. American Association for Cancer Research 101st Annual Meeting 70(8_suppl):275. e-Pub 2010.
Tsimberidou AM, Vaklavas C, Wen S, Hong D, Ng C, Naing A, Uehara C, Wolff R, Kurzrock R. Clinical outcomes and prognostic factors in 83 patients with pancreatic cancer treated in phase I clinical trials at M.D. Anderson Cancer Center. American Association for Cancer Research 101st Annual Meeting 70(8suppl):2771. e-Pub 2010.
Alba F, Ng C, Wood CG, Matin SF. Active surveillance of an incidental renal mass in the setting of an active or recently treated non-renal malignancy. American Society of Clinical Oncology (ASCO) 2010 Genitourinary Cancers Symposium:310. e-Pub 2010.
Patnana M, Vikram R, Ng C, Sandler C. Clear cell renal cell carcinoma: multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) appearances. Society of Gastrointestinal Radiologists and Society of Uroradiology: Abdominal Radiology Course. e-Pub 2010.
Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND. Results of adopting posterior retroperitoneoscopic adrenalectomy into surgical care. Southern Surgical Association 122nd Annual Meeting 212(4):665-667, 2010. e-Pub 2010.
Kurzrock R, Sherman S, Pfister D, Cohen RB, Ball D, Hong D, Ng CS, Frye J, Ratain MJ, Salgia R. Long term results in patients (pts) with medullary thyroid cancer (MTC) enrolled in a Phase 1 study of XL184 (BMS 907351), an oral inhibitor of MET, VEGFR2 and RET. 14th International Thyroid Congress:Abst OC-019, 2010. e-Pub 2010.
Melancon MP, Lu W, Huang Q, Thapa P, Zhou D, Ng CS, Li C. Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813. Proceedings of the 2010 World Molecular Imaging Congress, 2010. e-Pub 2010.
Jain RK, Lee J, Ng CS, Hong D, Gong J, Naing A, Wheler J, Kurzrock R. Survival outcomes of patients who develop new lesions while participating on phase I oncology studies. American Society of Clinical Oncology (ASCO) 46th Annual Meeting 28(15_suppl), 2010. e-Pub 2010.
Kurzrock R, Cohen EE, Sherman SI, Pfister DG, Cohen RB, Ball D, Hong DS, Ng CS, Salgia R, Ratain MJ. Long term results in a cohort of medullary thyroid cancer (MTC) patients (pts) in a phase 1 study of XL184 (BMS 907351), an oral inhibitor of MET, VEGFR2 and RET. Meeting Abstract: 2010 ASCO Annual Meeting 28(15_suppl), 2010. e-Pub 2010.
Falchook GS, Wheler JJ, Naing A, Hong DS, Moulder SL, Piha-Paul SA, Ng CS, Jackson E, Kurzrock R. A phase I study of bevacizumab in combination with sunitinib, sorafenib, and erlotinib plus cetuximab, and trastuzumab plus lapatinib. American Society of Clinical Oncology (ASCO) 46th Annual Meeting 28(15_suppl), 2010. e-Pub 2010.
Patnana M, Vikram R, Ng C, Sandler C. Clear cell renal cell carcinoma: MDCT and MRI appearances. 110th Annual Meeting of the American Roentgen Ray Society 194(5_suppl):e330, 2010. e-Pub 2010.
Yao JC, Phan A, Hess KR, Fogelman D, Jacobs C, Dagohoy CG, Leary CC, Ng CS. Randomized run-in study of bevacizumab and everolimus in low-to intermediate-grade neuroendocrine tumors (LGNETs) using perfusion CT (pCT) as functional biomarker. North American Neuroendocrine Tumor Society 3rd Annual Meeting 40(2):325-336, 2010. e-Pub 2010.
Fu S, Naing A, Moulder SL, Falchook GS, Culotta KS, Zhang Y, Madoff DC, Ng CS, Lim J, Kurzrock R. A phase I study of hepatic arterial infusion of nab-paclitaxel in patients with predominant hepatic metastases. American Society of Clinical Oncology 46th Annual Meeting 28(15_suppl), 2010. e-Pub 2010.
Alba F, Ng C, Wood CG, Matin SF. Active surveillance of an incidental renal mass in the setting of an active or recently treated non-renal malignancy. The 10th Annual Meeting of the Society of Urologic Oncology in Conjunction with the World Urological Oncology Federation:109. e-Pub 2009.
Yao JC, Phan A, Ng C, Fogleman D, Stephens MC, Dagohoy CG, Leary CC. Treatment-emergent tumor blood flow changes among patients with advanced low or intermediate grade neuroendocrine carcinoma treated with everolimus and bevacizumab. Chemotherapy Foundation Symposium XXVII Innovative Cancer Therapy For Tomorrow 10(1_suppl):25. e-Pub 2009.
Tian, M, Wen X, Jackson E, Uthamanthil R, Ng C, Gelovani J, Li C. Preclinical MR imaging of rhesus monkeys with PG-Gd: a novel blood pool contrast imaging agent. Radiological Society of North America (RSNA) 2009 Scientific Assembly and Annual Meeting 6(4):289-97. e-Pub 2009.
Kurzrock R, Sherman S, Pfister D, Cohen RB, Ball D, Hong D, Ng C, Frye J, Janisch L, Ratain MJ, Salgia R. Preliminary results of a phase 1 study of XL184, a MET, VEGFR2 and RET receptor tyrosine kinase inhibitor (TKI), administered orally to patients with medullary thyroid cancer (TC). American Thyroid Association 80th Annual Meeting 19(s1):2-70. e-Pub 2009.
Kurzrock R, Sherman S, Pfister D, Cohen RB, Ball D, Hong D, Ng C, Frye J, Janisch L, Ratain MJ, Salgia R. Preliminary results of a phase 1 study of XL184, a MET, VEGFR2 and RET receptor tyrosine kinase inhibitor (TKI), administered orally to patients with Thyroid Cancer (TC). World Congress on Thyroid Cancer. e-Pub 2009.
Vaklavas C, Tsimberidou AM, Moulder S, Ng C, Naing A, Daring S, Bedikian A, Uehara C, Kurzrock R. A phase I study dose escalation clinical study of hepatic intraarterial cisplatin, combination systemic intravenous liposomal doxorubicin in patients advanced cancer dominant liver involvement. American Society of Clinical Oncology 45th Annual Meeting 27(15_suppl). e-Pub 2009.
Vaklavas C, Tsimberidou AM, Moulder S, Ng C, Naing A, Daring S, Bedikian A, Uehara C, Kurzrock R. A phase I study dose escalation clinical study of hepatic intra-arterial cisplatin, combination systemic intravenous liposomal doxorubicin in patients advanced cancer dominant liver involvement. American Society of Clinical Oncology 45th Annual Meeting 27(15_suppl), 2009. e-Pub 2009.
Lambert LA, Katz MHG, Lambert DH, Overman M, Eng C, Wolff RA, Yao J, Ng C, Beaty K, Hernandez E, Mansfield PF. Clinical and pathologic characteristics of adenocarcinoid tumors of the appendix: more adeno, less carcinoid. The Society of Surgical Oncology Annual Cancer Symposium 16(1_suppl):67. e-Pub 2009.
Wen X, Jackson EF, Uthamanthil R, Ng CS, Gelovani JG, Tian M, Li C. Pharmacokinetics and MR imaging of rhesus monkeys with PG-Gd, a blood pool imaging agent. Proceedings of the 2009 World Molecular Imaging Congress 12(1_suppl):S389, 2009. e-Pub 2009.
Chandler A, Pan T, Wei W, Herron DH, Anderson EF, Ng CS. Evaluation of automated versus manual registration techniques for motion correction of lung tumors in helical breath hold CT images. European Congress of Radiology Annual Meeting 19(1_suppl):S157, 2009. e-Pub 2009.
Malhotra K, Haygood T, Ng C, Chasen B, McEnery K, Chasen M. Secondary displacement of long term central venous catheters into the azygous arch. 95th Radiological Society of North America Scientific Assembly and Annual Meeting, 2009. e-Pub 2009.
Chandler A, Herron DH, Anderson EF, Wei W, Yao J, Ng C. The effects of temporal sub-sampling on estimates of computed tomography perfusion parameters in abdominal tissues. 95th Radiological Society of North America Scientific Assembly and Annual Meeting, 2009. e-Pub 2009.
Tian M, Wen X, Jackson EF, Uthamanthil R, Ng C, Gelovani J, Li C. Pharmacokinetics and MR imaging of rhesus monkeys with PG-Gd, a blood pool imaging agent. Radiological Society of North America (RSNA) 2009 Scientific Assembly and Annual Meeting 12(1_suppl):S389, 2009. e-Pub 2009.
Lu W, Melancon MP, Huang Q, Thapa P, Wen X, Xiong C, Zhou D, Ng C, Li C. Mechanism for the uptake of long circulating biodegradable polymeric molecular resonance contrast agent in tumor necrotic area. American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition 2009, 2009. e-Pub 2009.
Falchook GS, Moulder S, Wheler JJ, Naing A, Hong D, Ng C, Jackson E, Jiang Y, Kurzrock R. Combination trastuzumab, lapatinib, and bevacizumab in HER+ breast cancer and other malignancies. American Society of Clinical Oncology (ASCO) 2009 Breast Cancer Symposium:244, 2009. e-Pub 2009.
Melancon MP, Lu W, Huang Q, Thapa P, Wen X, Xiong C, Zhou D, Ng C, Li C. Mechanism for the uptake of long circulating biodegradable polymeric MR contrast agent in tumor necrotic area. World Molecular Imaging Congress 12(1_suppl):S440, 2009. e-Pub 2009.
Melancon MP, Huang Q, May S, Brown B, Sano D, Myers J, Ng C, Li C. Theranostics of head & neck cancer using targeted hollow gold nanoshells. World Molecular Imaging Congress 12(1_Suppl):S429, 2009. e-Pub 2009.
Chandler A, Pan T, Wei W, Anderson EF, Herron DH, Yao JC, Ng CS. The effects of temporal sub-sampling/shifting on estimates of CT perfusion parameters in abdominal tissues. American Association of Physicists in Medicine 51st Annual Meeting, 2009. e-Pub 2009.
Falchook GS, Wheler JJ, Tannir NM, Naing A, Jackson EF, Hong D, Lawforn KN, Ng CS, Amin H, Kurzrock R. Hypoxia-inducible factor-1α (HIF-1α) modulation in combination with anti-angiogenic therapy. American Society of Clinical Oncology (ASCO) 45th Annual Meeting 27(15_suppl), 2009. e-Pub 2009.
Moroney JM, Coleman RL, Hong DS, Wheler JJ, Ng C, Bodurka DC, Falchook G, Naing A, Kurzrock R. A phase I trial of liposomal doxorubicin (D), bevacizumab (A), and temsirolimus (T) in advanced malignancy. American Society of Clinical Oncology (ASCO) 45th Annual Meeting 27(15_suppl), 2009. e-Pub 2009.
Haygood T, O'Sullivan P, Yamal J, Liles L, Madewell J, Chasen B, Fitzgerald N, Costelloe C, Ng C, Sandler C, Lano E, McEnery K, Jr MW. Determination of central line position in the superior vena cava or azygous vein on frontal chest radiographs. American Roentgen Ray Society (ARRS) 109th Annual Meeting 192(5 Suppl):(E090), 2009. e-Pub 2009.
Tsimberidou AM, Hong D, Ng C, Wheler J, Naing A, Bedikian AY, Eng C, Fortier A, Uehara C, Kurzrock R. A phase I study of hepatic arterial infusion of Oxaliplatin in combination with systemic Fluorouracil, Leucovorin and Avastin for patients with advanced solid tumors metastatic to the liver. 100th Annual Meeting of the American Association for Cancer Research 69(9_suppl):3595, 2009. e-Pub 2009.
Ng CS, Bankson JA, Kundra V, Waterton JC, Jackson EF. Reproducibility and cross-validation of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model. International Society for Magnetic Resonance in Medicine 17th Scientific Meeting and Exhibition:349, 2009. e-Pub 2009.
Naing A, Kurzrock R, Chen H, Hong DS, Falchook G, Doyle L, Lawhorn K, Burger AM, Ng C, Amin H, LoRusso PM. Multicenter Phase I clinical trial of an insulin like growth factor (IGF-R) inhibitor ( IMC-A12) in combination with a mammalian target of rapamycin (mTOR) inhibitor (CCI-779) to overcome resistance to mTOR inhibition. American Association for Cancer Research-European Organization for Research and Treatment of Cancer-National Cancer Institutes Molecular Targets and Cancer Therapeutics Conference 8(12_suppl):B61, 2009. e-Pub 2009.
Lambert LA, Katz MHG, Lambert DH, Overman M, Eng C, Wolff RA, Yao J, Ng C, Beaty K, Hernandez E, Mansfield PF. Clinical and pathologic characteristics of adenocarcinoid tumors of the appendix: more adeno, less carcinoid. 6th International Workshop on Peritoneal Surface Malignancy 16(1_suppl). e-Pub 2008.
Chandler A, Pan T, Herron DH, Anderson EF, Wei W, Ng CS. Evaluation of automated registration techniques for motion correction of lung tumors in helical breath hold CT images. Radiological Society of North America Scientific Assembly and Annual Meeting. e-Pub 2008.
Vikram R, Ng CS, Tamboli P, Tannir N, Matin S, Wood C, Jonasch E, Sandler C. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiological Society of North America Annual Meeting 29(3). e-Pub 2008.
Kurzrock R, Sherman S, Hong D, Ng C, Frye J, Janisch L, Ratain MJ, Salgia R. Preliminary results of a phase 1 study of XL184, a MET, VEGFR2 and RET kinase inhibitor, administered orally to patients with medullary thyroid cancer (MTC). American Association of Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer International Conference, Molecular Targets and Cancer Therapeutics, Discovery, Biology, and Clinical Applications 119:2660-6. e-Pub 2008.
Kurzrock R, Sherman S, Hong D, Ng C, Frye J, Janisch L, Ratain MJ, Salgia R. Preliminary results of a phase 1 study of XL184, a MET, VEGFR2 and RET kinase inhibitor, administered orally to patients with medullary thyroid cancer (MTC). American Thyroid Association 79th Annual Meeting 18(1_suppl):S34. e-Pub 2008.
Fu S, Chintala L, Madoff D, Hong D, Naing A, Moulder S, Wheler J, Ng C, Lim J, Patterson M, Camacho L, Kurzrock R. A phase I study of hepatic arterial infusion of oxaliplatin plus intravenous fluorouracil, leucovorin and bevacizumab in patients with predominant hepatic metastases. American Society of Clinical Oncology Annual Meeting 26(15_suppl). e-Pub 2008.
Falchook GS, Jackson EF, Wheler JJ, Moulder S, Hong D, Naing A, Tannir NM, Lawhorn KN, Ng CS, Kurzrock R. Anti-angiogenic therapy in combination with hypoxia-inducible factor-1α (HIF-1α) modulation. American Society of Clinical Oncology (ASCO) 44th Annual Meeting 26(15_suppl), 2008. e-Pub 2008.
Moulder SL, Dhillon N, Hong DS, Ng CS, Camacho LH, Hersh EM, Grenier KA, Boytim ML, Dorr RT, Kurzrock R. A phase I study of imexon in combination with docetaxel (DOC) for the treatment of patients with breast, lung and prostate cancer. American Society of Clinical Oncology 44th Annual Meeting 26(15_suppl). e-Pub 2008.
Fu S, Chintala L, Madoff D, Hong D, Naing A, Moulder S, Wheler J, Ng C, Lim J, Patterson M, Camacho L, Kurzrock R. A phase I study of hepatic arterial infusion of oxaliplatin plus intravenous fluorouracil, leucovorin and bevacizumab in patients with predominant hepatic metastases. American Society of Clinical Oncology Annual Meeting 26(15_suppl), 2008.
Samuels J, Ng CS, Shaw A, Salahudeen A. Any rise in creatinine is associated with mortality in critically ill pediatric patients with cancer. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting. e-Pub 2008.
Nemunaitis JJ, Senzer N, Kurzrock R, Ng C, Das A, Atienza R, Zansen M, Ashworth S, Hong D. A phase I dose escalation study of E7080, a multikinase inhibitor, in patients with advanced solid tumors. American Society of Clinical Oncology (ASCO) 44th Annual Meeting 26(15_suppl), 2008. e-Pub 2008.
Katz MH, Mansfield PF, Wolff RA, Eng C, Ng C, Gonzalez-Moreno S, Laura LA. Incidence and impact of lymph node and non-peritoneal metastases in non-carcinoid epithelial tumors of the appendix. 61st Annual Meeting of the Society of Surgical Oncology 15(2_suppl):60, 2008. e-Pub 2008.
Lambert LA, Armstrong TS, Lee JJ, Katz MH, Eng C, Wolff RA, Ng CS, Smith ML, Gonzalez-Moreno S, Mansfield PF. Female sex and standardized mitomycin-c dose are associated with increased risk of neutropenia after hyperthermic intraperitoneal chemotherapy. Society of Surgical Oncology 61st Annual Cancer Symposium 25(18_suppl):56. e-Pub 2008.
Vikram R, Ng CS, Tamboli P, Tannir NM, Matin SF, Sandler CM, Jonasch E, Wood CG. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiological Society of North America Annual Meeting. e-Pub 2008.
Xu A, Sandler C, Kamat AM, Grossman HB, Dinney CP, Ng CS. Evaluating the effectiveness of MDCT urography in detecting upper tract neoplasms and the implications of urothelial thickening vs filling defects seen on imaging. Radiological Society of North America Scientific Assembly and Annual Meeting:VU21-16, 2008. e-Pub 2008.
Chandler A, Pan T, Herron DH, Anderson EF, Wei W, Ng CS. Evaluation of automated registration techniques for motion correction of lung tumors in helical breath hold computed tomography images. Radiological Society of North America Scientific Assembly and Annual Meeting. e-Pub 2008.
Salgia R, Sherman S, Hong D, Ng C, Janisch L, Ratain MJ, Kurzrock R. A phase 1 study of XL184, a RET, VEGFR2 & MET kinase inhibitor, in patients (pts) with advanced malignancies, including pts with medullary thyroid cancer (MTC). American Society of Clinical Oncology Annual Meeting 26(15_suppl), 2008. e-Pub 2008.
Ng CS, Wei W, Doyle TC, Courtney HM, Dixon AK, Freeman AH. Minimal-preparation abdomino-pelvic computed tomography in frail and elderly patients: prognostic value of colonic and extracolonic findings. Eur Radiol 18(1_suppl):67, 2008. e-Pub 2008.
Ng CS, Wei W, Doyle TC, Courtney HM, Dixon AK, Freeman AHB. Minimal-preparation abdomino-pelvic CT in frail and elderly patients: prognostic value of colonic and extracolonic findings. European Congress of Radiology Annual Meeting 18 suppl(1):145, 2008. e-Pub 2008.
Katz MH, Mansfield PF, Wolff RA, Eng C, Ng C, Gonzalez-Moreno S, Laura LA. Incidence and impact of lymph node and non-peritoneal metastases in non-carcinoid epithelial tumors of the appendix. American Society of Clinical Oncology (ASCO) 2008 Gastrointestinal Cancers Symposium, 2008. e-Pub 2008.
Vikram R, Ng CS, Tamboli P, Tannir NM, Matin SF, Sandler CM, Jonasch E, Wood CG. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiological Society of North America Annual Meeting 29(3). e-Pub 2007. PMID: 19448113.
Salgia R, Hong D, Sherman, Ng C, Frye J, Janisch L, Ratain MJ, Kurzrock R. A phase 1 dose-escalation study of the safety and pharmacokinetics (PK) of XL184, a VEGFR and MET kinase inhibitor, administered orally to patients (pts) with advanced malignancies. American Association of Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer International Conference 115(11_suppl), 2007. e-Pub 2007.
Hong DS, Camacho L, Ng CS, Wright J, Newman RA, Moulder S, Tannir N, Wheler J, Khan R, Kurzrock R. Phase I study of tipifarnib & sorafenib in advanced biopsiable cancer patients (NCI protocol 7156-supported by NCI grant UO1 CA062461). American Society of Clinical Oncology Annual Meeting 25(18_suppl):3549. e-Pub 2007.
Lambert LA, Armstrong TS, Lee JJ, Katz MH, Eng C, Wolff RA, Ng CS, Smith ML, Gonzalez-Moreno S, Mansfield PF. Female sex and standardized mitomycin-c dose are associated with increased risk of neutropenia after hyperthermic intraperitoneal chemotherapy. 61st Annual Meeting of the Society of Surgical Oncology 25(18_suppl):15091. e-Pub 2007.
Soriano AO, Braiteh F, Garcia-Manero G, Camacho LH, Hong D, Moulder S, Ng CS, Kurzrock R. Combination of 5-azacytidine (5-AZA) and valproic acid (VPA) in advanced solid cancers: a phase I study. American Society of Clinical Oncology Annual Meeting 25(18_suppl). e-Pub 2007.
Katz MH, Mansfield PF, Eng C, Wolff RA, Diaz PA, Ng CS, Lambert L. Is there a role for neoadjuvant chemotherapy in the management of non-carcinoid epithelial neoplasms of the appendix?. American Society of Clinical Oncology (ASCO) 43rd Annual Meeting 25(18_suppl). e-Pub 2007.
Dhillon N, Aggarwal B, Newman RA, Li L, Wolff RA, Abbruzzese JL, Hong DS, Camacho LH, Ng CS, Kurzrock R. Curcumin and pancreatic cancer: phase II clinical trial experience. American Society of Clinical Oncology Annual Meeting 25(18_suppl). e-Pub 2007.
Salgia R, Hong DS, Camacho LH, Ng CS, Janisch L, Ratain J, Kurzrock R. A phase I dose-escalation study of the safety and pharmacokinetics (PK) of XL184, a VEGFR and MET kinase inhibitor, administered orally to patients (pts) with advanced malignancies. American Society of Clinical Oncology (ASCO) 43rd Annual Meeting 25(18_suppl). e-Pub 2007.
Lin, Ng CS, Krishnan S, Kurland B, Rodriguez-Bigas MA, Crane C, Skibber JM, Matamoros A, Feig BW, Ayers GD, Hamilton SR, Janjan NA, Curley SA. Does maintenance capecitabine and celecoxib improve outcomes after complete response to treatment for metastatic colorectal cancer?. American Society of Clinical Oncology 25(18), 2007. e-Pub 2007.
Falchook GS, Dhillon H, Moulder S, Duvic M, Ng CS, Hong D, Camacho L, Lim J, Wang M, Fayad L, Kurzrock R. Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies. American Society of Clinical Oncology 43rd Annual Meeting 25(18_suppl). e-Pub 2007.
Kurzrock R, Akerley W, Hong D, Ng CS, Warren T, Zavitz K, McCage C, Laughlin M, Camacho L. Two phase I studies of MPC-6827, a novel vascular disrupting agent (VDA), in patients with advanced solid tumors and CNS metastases. American Society of Clinical Oncology Annual Meeting 25(18_suppl):3604, 2007. e-Pub 2007.
Dhillon N, Moulder S, Hong DS, Ng C, Camacho LH, Hersh E, Grenier K, Dorr R, Kurzrock R. Phase I trial of imexon and docetaxel in patients with previously-treated stage IV non-small cell lung cancer, metastatic breast cancer or hormone-refractory prostate cancer. American Association for Cancer Research (AACR) Annual Meeting: Proceedings, #LB-351, 2007. e-Pub 2007.
Kodama Y, Ng CS, Herbst RS, Abbruzzese JL, Johnson VE, Barron BJ, Charnsangavej C, Mullani NA. Tumor blood flow measured by functional CT and O15-labeled water PET: a comparison study. European Congress of Radiology Annual Meeting 17(1_suppl):320 B778, 2007. e-Pub 2007.
Kodama Y, Ng CS, Herbst RS, Abbruzzese JL, Johnson VE, Barron BJ, Charnsangavej C, Mullani NA. Tumor blood flow measured by functional computed tomography and O15-labeled water positron emission tomography: A comparison study. European Congress of Radiology 17(1_suppl):320, 2007. e-Pub 2007.
Lambert LA, Armstrong TS, Lee JJ, Katz MH, Eng C, Wolff RA, Ng CS, Smith ML, Gonzalez-Moreno S, Mansfield PF. Female sex and standardized mitomycin-c dose are associated with increased risk of neutropenia after hyperthermic intraperitoneal chemotherapy. Society of Surgical Oncology 61st Annual Cancer Symposium 18(18_suppl):15091, 2007. e-Pub 2007.
Dhillon N, Bakkannagari S, Ng CS, Lim J, Duvic M, Kurzrock R. Cutaneous T cell lymphoma: responses in phase 1 trial of combination therapy with liposomal doxorubicin, bortezomib, and gemcitabine. American Society of Hematology 48th Annual Meeting 108(1):2466. e-Pub 2006.
Ng CS, Pan T, Wang X, Anderson EF, Herron DH, Kurzrock R, Thall PF, Charnsangavej C. Reproducibility of perfusion parameters obtained from dynamic contrast enhanced computed tomography (DCE-CT) in liver tumors. Radiological Society of North America (RSNA) 92nd Scientific Assembly and Annual Meeting 212. e-Pub 2006.
Ng CS, Jackson EF, Ashton E, Rauning DL, Kelcz F, Kurzrock R, Charnsangavej C, Evelhoch J, McShane TM. The reproducibility of perfusion parameters obtained from dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in liver and lung tumors, and implications for sample size in clinical trials using DCE-MRI. European Organization for Research and Treatment of Cancer (EORTC) Annual Meeting 4(12_suppl):43. e-Pub 2006.
Kurzrock R, Camacho L, Hong D, Ng CS, Janisch L, Ratain MJ, Salgie R. A phase I dose-escalation study of the safety and pharmacokinetics of a XL184, a VEGFR and met kinase inhibitor, administered orally to subjects with advanced malignancies. European Organization for Research and Treatment of Cancer Annual Meeting 4(12):124. e-Pub 2006.
Szklaruk J, Tamm EP, Ng C, Balachandran A, Bhosale P, Ma J. 1.5T vs 3T body MRI: qualitative and quantitative comparison of T2 weighted images for liver lesion detection. International Society of Magnetic Resonance in Medicine 14th Scientific Meeting & Exhibition 4(12):124. e-Pub 2006.
Szklaruk J, Tamm EP, Ng CS, Balachandran A, Bhosale P. Evaluation of liver lesions by T2-weighted imaging at 3T and 1.5T magnetic field strengths. American Roentgen Ray Society 106th Annual Meeting 186(4_suppl):a104. e-Pub 2006. PMID: 16357386.
Ng CS, Rauning DL, Ashton E, Jackson EF, Kelcz F, Kurzrock R, Evelhoch J, Charnsangavej C, McShane TM. Morphologic assessments of tumor size: scan-rescan reproducibility of long- and short-axis measurements using manual and automated 3-dimensional assessments in liver and lung tumors using magnetic resonance imaging (MRI). 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics 4(12_suppl):45, 2006. e-Pub 2006.
Braiteh FS, Yao J, Camacho LH, Ng C, Hong DS, Harris P, Dhillon N, Kurzrock R. Phase I study of the safety and efficacy of atiprimod, a novel azaspirine, for patients with advanced cancer. American Society of Clinical Oncology Annual Meeting 24(18_suppl):13050, 2006. e-Pub 2006.
Braiteh FS, Yao J, Camacho LH, Ng C, Hong DS, Harris P, Dhillon N, Kurzrock R. Phase I study of low-dose hypomethylating agent azacitidine (5-AC) combined with the histone deacetylase inhibitor valproic acid (VPA) in patients with advanced cancers. American Society of Clinical Oncology (ASCO) 42nd Annual Meeting 24(18_suppl):3060, 2006. e-Pub 2006.
Kodama Y, Ng CS, Tsung TW, Johnson VE, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C. The ability of CT to determine the degree of hepatic steatosis. UK Radiological Congress 11:11, 2006. e-Pub 2006.
Kodama Y, Ng CS, Tsung TW, Johnson VE, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C. The ability of CT to determine the degree of hepatic steatosis. 106th American Roentgen Ray Society Annual Meeting 186(4_suppl):#221, 2006. e-Pub 2006.
Samuels JA, Finkel KW, Foringer JR, Ng C, Shaw AD. Small increases in creatinine prolong ICU stay and increase hospital mortality. American Society of Nephrology 38th Annual Renal Week Meeting. e-Pub 2005.
Tannir NM, Jonasch E, McMichael C, Wang X, Wooten L, Ng CS. A phase II trial of gemcitabine plus capecitabine (GX) in patients with advanced renal cell cancer (mRCC) previously treated with immunotherapy. American Society of Clinical Oncology Annual Meeting 23(16_suppl):4598. e-Pub 2005.
Szklaruk J, Faria SC, Yao JC, Ng CS, Charnsangavej C. Changes in functional CT parameters and interobserver variability in patients with metastatic carcinoid treated with anti-angiogenic therapy. American Roentgen Ray Society Annual Meeting 184(4_suppl). e-Pub 2005.
Yao JC, Ng C, Hoff PM, Phan AT, Hess K, Chen H, Wang X, Abbruzzese JL, Ajani JA. Improved progression free survival (PFS), and rapid, sustained decrease in tumor perfusion among patients with advanced carcinoid treated with bevacizumab. American Society of Clinical Oncology (ASCO) 41st Annual Meeting 23(16_suppl):309s. e-Pub 2005.
Andtbacka RHI, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PWT, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with Imatinib. Society of Surgical Oncology Annual Meeting 12(S35). e-Pub 2005.
Ng CS, Faria SC, Yao J, Wang X, Charnsangavej C. Changes in dynamic contrast-enhanced CT (DCE-CT) parameters in patients with carcinoid liver metastases undergoing anti-VEGF versus interferon therapy. Radiological Society of North America (RSNA) 91st Scientific Assembly and Annual Meeting:508, 2005. e-Pub 2005.
Ng CS, Faria SC, Yao J, Wang X, Charnsangavej C. Changes in dynamic contrast-enhanced computed tomography (DCE-CT) parameters in patients with carcinoid liver metastases undergoing anti-VEGF versus interferon therapy. International Cancer Imaging Society Annual Meeting 5:S94, 2005. e-Pub 2005.
Cesta MA, Shaw A, Nates JL, Ng C. Low hemoglobin levels are associated with higher mortality in cancer patients admitted to the surgical ICU. The Anesthesiology 2005 Annual Meeting 13(A296 epub). e-Pub 2005.
Ng CS, Szklaruk J, Kundra V, Gershenwald JE, Prieto VG, Bedi DG, Jacobson MG. The spectrum of manifestations of metastatic malignant melanoma. American Roentgen Ray Society (ARRS) 105th Annual Meeting 184(4_suppl), 2005. e-Pub 2005.
Aloia T, Gershenwald J, Ross M, Lee J, Johnson M, Cormier J, Ng CS, Mansfield P. Utility of CT or MRI staging in melanoma patients with a positive sentinel lymphadenectomy. Sentinel Node Conference. e-Pub 2004.
Ng CS, Faria SC, Jackson EF, Herbst RS, Charnsangavej C. Changes in dynamic contrast enhanced computed tomography (DCE-CT) parameters in patients undergoing anti-VEGFR/PDGFR therapy. Radiological Society of North America (RSNA) 90th Scientific Assembly and Annual Meeting:278, 2004. e-Pub 2004.
Ng CS, Kundra V, Jacobson MJ, Szklaruk J, Bedi DG. The spectrum of manifestations of metastatic malignant melanoma. European Congress of Radiology Annual Meeting 14(2_suppl):358, 2004. e-Pub 2004.
Szklaruk J, Faria SC, Yao J, Ng CS, Charnsangavej C. Evaluation of interobserver variability and changes in functional CT parameters in patients with metastatic carcinoid treated with anti-VEGF anti-angiogenic therapy. Radiological Society of North America Annual Meeting:237, 2004. e-Pub 2004.
Szklaruk J, Ng CS, Faria SC. Evaluation of the independent contribution of T2 weighted and dynamic post-gadolinium images in MRI - evaluation of the liver. European Society for Magnetic Resonance in Medicine and Biology 21st Annual Meeting:(C-078) ePub, 2004. e-Pub 2004.
Tannir NM, Wang X, Ng CS, Poulter VA, Mathew P, Siefker-Radtke AO, Jonasch E, Pagliaro LC, Cohen L, Millikan RE. A randomized phase III trial of low dose versus intermediate dose interferon alfa (IFN) as front-line therapy in advanced progressive renal cell cancer (RCC). American Society of Clinical Oncology (ASCO) 40th Annual Meeting (Post-Meeting Edition) 22(14S (July 15 Suppl)):460, 2004. e-Pub 2004.
McShane T, Ashton E, Jackson E, Kelcz F, Yeh B, Ng CS, Charnsangavej C, Steinfeldt H, Reich S, Pithavala Y, Evelhoch J. Dynamic contrast enhanced MRI evaluation of the effects of the VEGR/PDGF receptor tyrosine kinase inhibitor AG-013736 on tumor vasculature in a phase I clinical trial. International Society of Magnetic Resonance in Medicine Annual Meeting 11:154, 2004. e-Pub 2004.
Ng CS, Palmer CR. Assessing diagnostic confidence: example from a randomised controlled trial of abdomino-pelvic CT for acute abdominal pain of uncertain etiology - being confidently wrong can be dangerous for health. Radiological Society of North America 88th Scientific Assembly and Annual Meeting 225(Suppl P):555. e-Pub 2003.
Faria S, Ng C, Phongkitkarun S, Kobayashi S, Lee T, Charnsangavej C. Inter-observer variability in the measurement of functional CT parameters in patients with hepatic metastases. Radiological Society of North America Annual Meeting 225(Suppl P). e-Pub 2003.
Bedi DG, Gombos D, Ng CS, Singh SK. Sonography of the eye: normal anatomy and pathology. (Ultrasound of the eye). World Federation for Ultrasound in Medicine and Biology 29(5_suppl):S125. e-Pub 2003.
Scaife CL, Ng CS, Ellis LM, Vauthey JN, Charnsangavej C, Curley SA. Accuracy of preoperative imaging of hepatic tumors with helical computed tomography. Society of Surgical Oncology 56th Annual Cancer Symposium 10:S29-S30. e-Pub 2003.
Phongkitkarun S, Kan Z, Kobayashi S, Ng C, Lee TY, Charnsangavej C. Vascular permeability of a murine mammary tumor model assessed by functional CT using low and high molecular weight contrast media. Radiological Society of North America (RSNA) 89th Scientific Assembly and Annual Meeting 225(Suppl P):335, 2003. e-Pub 2003.
Faria SC, Varavithya V, Phongkitkarun S, Ng CS, Tamm EP, Charnsangavej C. Imaging approach to resectability evaluation of suprapancreatic and hilar cholangiocarcinoma. Radiological Society of North America Annual Meeting 225(Suppl_p), 2003. e-Pub 2003.
Ng CS, Palmer CR. Assessing diagnostic confidence: example from a randomised controlled trial of abdomino-pelvic computed tomography for acute abdominal pain of uncertain etiology - being confidently wrong can be dangerous for health. European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Annual Meeting 13(2_suppl):S120, 2003. e-Pub 2003.
See TC, Ng CS, Dixon AK, Watson CJ. The role of computed tomography in the diagnosis and management of atypical appendicitis: case illustrations. European Society for Gastrointestinal and Abdominal Radiology Annual Meeting 13(2_suppl):S144, 2003. e-Pub 2003.
Faria S, Ng CS, Phongkitkarun S, Hess KR, Mullani NA, Charnsangavej C. Comparison of blood flow measurements obtained by 150-positron emission tomography and functional computed tomography in patients with solid tumors. Radiological Society of North America (RSNA) 89th Scientific Assembly and Annual Meeting 225(Suppl P):534, 2003. e-Pub 2003.
Kobayashi S, Kazama T, Faria SC, Madoff DC, Ng CS, Charnsangavej C. Changes in hepatic perfusion and morphology after portal vein embolization. Radiological Society of North America (RSNA) 88th Scientific Assembly and Annual Meeting 225(P). e-Pub 2002.
Fenstermacher MJ, Wood CP, Ng CS, Silverman PM. Multiplanar reformatting and 3-D volume rendering of multidetector, multiphase contrast-enhanced computed tomography for the diagnosis, staging, and surgical planning of renal tumors. Radiological Society of North America (RSNA) 88th Scientific Assembly and Annual Meeting 225:690. e-Pub 2002.
Szklaruk J, Ng CS, Tamm EP, Charnsangavej. What are those nodes called? A pictorial review of the abdominal nodal stations. Radiological Society of North America (RSNA) 88th Scientific Assembly and Annual Meeting 225(P). e-Pub 2002.
Ng CS, Watson CJE, Palmer CR, See TC, Beharry NA, Housden BA, Bradley JA, Dixon AK. A prospective randomised study of early abdomino-pelvic computed tomography (CT) in the management of patients with acute abdominal pain of indeterminate aetiology. European Congress of Radiology 178(3_suppl):41. e-Pub 2002.
Faria SC, Ng CS, Phongkitkarun S, Kobayashi S, Tamm EP, Charnsangavej C. Functional CT parameters and lesion enhancement measured by CT density in hepatic metastases. Radiological Society of North America (RSNA) 88th Scientific Assembly and Annual Meeting 225(P), 2002. e-Pub 2002.
Ng CS, Watson CJE, Palmer CR, See TC, Beharry NA, Housden BA, Bradley JA, Dixon AK. A prospective randomised study of early abdomino-pelvic computed tomography (CT) in the management of patients with acute abdominal pain of indeterminate aetiology. American Roentgen Ray Society 102nd Annual Meeting 178(3_suppl), 2002. e-Pub 2002.
Ng CS, Doyle T, Pinto E, Courtney H, Prevost T, Freeman AH, Dixon AK. Caecal carcinoma in the elderly: serosal margin-blurring and terminal ileal wall thickening, useful signs in minimal preparation CT. European Society of Gastrointestinal and Abdominal Radiology (ESGAR) 12th Annual Meeting 11:C2, 2001. e-Pub 2001.
Ng CS, Doyle T, Courtney H, Bull R, Pinto E, Prevost T, Freeman AH, Dixon AK. Evaluation of CT in identifying colo-rectal carcinoma in the frail elderly patient. European Congress of Radiology 11(2_suppl):141. e-Pub 2001.
Ng CS, Doyle T, Courtney H, Bull R, Pinto E, Prevost T, Freeman AH, Dixon AK. Extra-colonic abnormalities identified during abdomino-pelvic CT for colo-rectal carcinoma in the frail elderly patient. European Congress of Radiology Annual Meeting. e-Pub 2001.
Patel RN, Doyle T, Ng CS. Imaging for intended partial liver resection surgery: a retrospective analysis. European Congress of Radiology 11(2_suppl):335. e-Pub 2001.
Russell CJH, Ng CS, Watson CJE, Freeman AH, Bradley JA, Dixon AK. Early CT reduces diagnostic uncertainty in acute diverticulitis. European Society of Gastrointestinal and Abdominal Radiology (ESGAR) 12th Annual Meeting 11:C36, 2001. e-Pub 2001.
See TC, Ng CS, Watson CJ, Dixon AK. Appendicitis: spectrum of appearances on helical computed tomography. UK Radiological Congress Annual Meeting, 2001. e-Pub 2001.
Ng CS, Doyle T, Courtney H, Bull R, Pinto E, Prevost T, Freeman AH, Dixon AK. Extracolonic abnormalities identified during abdominopelvic CT for colorectal carcinoma in the frail elderly patient. UK Radiological Congress 2001:27-28, 2001. e-Pub 2001.
Ng CS, Doyle T, Courtney H, Bull R, Pinto E, Prevost T, Freeman AH, Dixon AK. Evaluation of CT in identifying colo-rectal carcinoma in the frail elderly patient. American Roentgen Ray Society (ARRS) 101st Annual Meeting 176(3_suppl):12, 2001. e-Pub 2001.
See TC, Ng CS, Watson CJ, Dixon AK. Appendicitis: spectrum of appearances on helical computed tomography. European Congress of Radiology Annual Meeting. e-Pub 1999.
Ford MB, Sigurdson AJ, Stewart SE, Ng CS. Lung Cancer after Breast Cancer: the Role of Smoking and XRT. American Society for Preventive Oncology Annual Meeting. e-Pub 1999.
Ng CS, Markose G, Freeman AH. The impact of spiral CT on the diagnosis of unsuspected colitis. European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Annual Meeting 10:D11, 1999. e-Pub 1999.
Old SE, Balan KK, Ng CS, Parry-Jones DR, Marcus RE. Gamma camera positron emission tomography (PET) in lymphoma. European Association of Nuclear Medicine Annual Congress 26:978, 1999. e-Pub 1999.
Ford MB, Sigurdson AJ, Stewart SE, Ng CS. Lung cancer after breast cancer: the role of radiation therapy and smoking. European Cancer Conference 35(4_suppl):S248, 1999. e-Pub 1999.
Old SE, Balan KK, Ng CS, Parry-Jones DR, Marcus RE. Gamma camera positron emission tomography (PET) in lymphoma. British Cancer Research Meeting 80(suppl 2):1-113, 1999. e-Pub 1999.
Old SE, Balan KK, Ng CS, Parry-Jones DR, Marcus RE. Gamma camera positron emission tomography (PET) in lymphoma. Society of Nuclear Medicine 46th Annual Meeting 40(5 Suppl):1P-362P, 1999. e-Pub 1999.
Stewart E, Sigurdson AJ, Ford MB, Ng CS. Lung cancer after breast cancer: does smoking or radiation therapy increase the risk of bronchoalveolar carcinoma?. Society for Epidemiologic Research 32nd Annual Meeting 159(11_suppl), 1999. e-Pub 1999.
Old SE, Balan KK, Ng CS, Parry-Jones DR, Marcus RE. Gamma camera positron emission tomography (PET) in lymphoma. British Nuclear Medicine Society 27th Annual Meeting 20(5):20, 1999. e-Pub 1999.
Ng CS, Munden RF, Libshitz HI. Malignant pleural mesothelioma: the spectrum of manifestations on CT in 70 cases. American Roentgen Ray Society (ARRS) 99th Annual Meeting 172(3 Suppl):142, 1999. e-Pub 1999.
Ng CS, Munden RF, Libshitz HI. Malignant pleural mesothelioma: the spectrum of manifestations on CT in 70 cases. European Congress of Radiology Annual Meeting 35(Suppl4), 1999. e-Pub 1999.
Ng CS, Loyer EM, Iyer R, David C, Dubrow R, Cleary KR, Evans DB, Charnsangavej C. Venous invasion in pancreatic carcinoma: CT-pathologic correlation. Radiology 1998 - Imaging, Science & Oncology 71 (suppl):29. e-Pub 1998.
Ng CS, Loyer EM, Iyer R, David C, Dubrow R, Cleary KR, Evans DB, Charnsangavej C. Venous invasion in pancreatic carcinoma: CT-pathologic correlation. American Roentgen Ray Society(ARRS) 98th Annual Meeting 170(4_suppl):41. e-Pub 1998.
Ng CS, Fenstermacher MJ, Pisters P. MR imaging of tumors involving the perineum: imaging anatomy, diagnosis and staging, treatment evaluation and surgical correlation. American Roentgen Ray Society (ARRS) 98th Annual Meeting 209(P), 1998. e-Pub 1998.
Ng CS, Munden, R. F, Libshitz, H. I.. Malignant pleural mesothelioma: the spectrum of manifestations on CT in 70 cases. European Respiratory Society Annual Congress 14(Supp), 1998. e-Pub 1998.
Ng CS, Fenstermacher MJ, Pisters P. MR imaging of tumors involving the perineum: imaging anatomy, diagnosis and staging, treatment evaluation and surgical correlation. Radiology 1998 - Imaging, Science & Oncology 35(Suppl4), 1998. e-Pub 1998.
Ng CS, Fenstermacher MJ, Pisters P. MR imaging of tumors involving the perineum: imaging anatomy, diagnosis and staging, treatment evaluation, and surgical correlation. Radiological Society of North America (RSNA) 84th Scientific Assembly and Annual Meeting 209(P), 1998. e-Pub 1998.
Ng CS, Loyer EM, David C, Dubrow R, Charnsangavej C. The appearances of renal cell carcinoma metastases in the pancreas using 3-phase intravenous enhanced helical computed tomography. Radiology 1998 - Imaging, Science & Oncology 71 suppl:89, 1998. e-Pub 1998.
Ng CS, Wells AU, Padley SPG. A CT sign of pulmonary hypertension: the ratio of main pulmonary artery to aortic diameter. Society of Thoracic Radiology Annual Meeting 1998:12, 1998. e-Pub 1998.
Iyer RB, Shah SP, Ng C, Hess K, Jackson EF. Hepatic lesion detection: T2 weighted fast spin echo vs. breathhold single shot fast spin echo. Association of University Radiologists (AUR) 46th Annual Meeting 5(10):746, 1998. e-Pub 1998.
Ng CS, Wells AU, Desai SR, Rubens MB, Padley SPG, Hansell DM. The detection of signs of small airway disease: a comparison of inspiratory and expiratory thin-section computed tomography. Radiology 1997 - Imaging, Science and Oncology 70 (suppl):23. e-Pub 1997.
Ng CS, Wells AU, Padley SPG. A CT sign of pulmonary hypertension: the ratio of main pulmonary artery to aortic diameter. Radiology 1997 - Imaging, Science, and Oncology 70 (suppl):23, 1997. e-Pub 1997.
Ng CS, Husband JES, MacVicar D, Cunningham D. Correlation of CT with histopathological findings in patients with gastric and esophageal carcinomas following neo-adjuvant chemotherapy. Radiology 1997 - Imaging, Science, and Oncology 70(1_suppl):82, 1997. e-Pub 1997.
Ng CS, Wells AU, Desai SR, Rubens MB, Padley SPG, Hansell DM. The detection of signs of small airways disease: a comparison of inspiratory and expiratory thin-section computed tomography. European Congress of Radiology Annual Meeting 70(1_suppl):23, 1997. e-Pub 1997.
Ng CS, Wells, A.U., Padley, S.P.G.. The results of 500 percutaneous bone biopsies. Annual Scientific Meeting of Hong Kong College of Radiologists:61, 1997. e-Pub 1997.
Ng CS, Husband JES, MacVicar D, Cunningham DC. Correlation of CT with histopathological findings in patients with gastric and oesophageal carcinomas following neo-adjuvant chemotherapy. European Congress of Radiology Annual Meeting 7(1_suppl):S245, 1997. e-Pub 1997.
Ng CS, Wells AU, Desai SR, Rubens MB, Padley SPG, Hansell DM. The detection of signs of small airways disease: a comparison of inspiratory and expiratory thin-section computed tomography. Society of Thoracic Radiology Annual Meeting 70(1_suppl):25. e-Pub 1997.
Ng CS, O'Donoghue J, Catnach SM, Williams R, Farrant P, Meire HB. The value of Doppler ultrasound in assessing the severity of liver disease in patients with primary biliary cirrhosis. British Medical Ultrasound Society 41. e-Pub 1996.
Ng CS, O'Donoghue J, Catnach SM, Williams R, Farrant P, Meire HB. Inter-and intra-observer accuracy in the doppler measurement of hepatic artery resistance index, portal vein velocity, portal vein diameter, and spleen size. British Medical Ultrasound Society 15. e-Pub 1996.
Toye R, Ng CS, Michell MJ, Given-Wilson R, Humphreys S, Nunnerley HB. Is this really breast disease? Manifestations of extra-mammary disease on imaging the breast. Radiological Society of North America Annual Meeting 197(P)(suppl):461, 1995. e-Pub 1995.
Ng CS, Salisbury JR, Darby A, Gishen P. Radiologically guided bone biopsies - results of 477 biopsies. Roentgen Centenary Congress:376, 1995. e-Pub 1995.
Ng CS, Toye R, Nunnerley HB, Michell MJ. The predictive value of mammographic signs for women referred for surgical biopsy following breast screening. Symposium Mammographicum 31:31. e-Pub 1994.
Ng CS, Toye R, Nunnerley HB, Michell MJ. Relationship between the level of suspicion for screening detected mammographic abnormalities and positive value of malignancy. Symposium Mammographicum, 1994. e-Pub 1994.
Toye R, Ng CS, Sonksen C, Nunnerley HB, Michell MJ. Mammographic manifestations of extra-mammary diseases. Symposium Mammographicum, 1990. e-Pub 1990.
Lee T, Burgers K, Ng CS, Zhang Z, Coleman R, Mannel R, Rosen M, Lee S. Effective Radiation Dose of Perfusion CT Exams of Ovarian Cancer Patients: A Multi-center Study. Society of Abdominal Radiology 2016 Annual Scientific Meeting and Educational Course.
Hamady M, Wilkins CJ, Ng CS, Philpott-Howard J, Gishen P. Percutaneous bone biopsy in osteomyelitis - seven years' experience. British Society of Interventional Radiology Annual Meeting.
Ng CS, deBruyn R, Gordon I. The investigation of reno-vascular hypertension in children: the accuracy of radioisotopes in detecting reno-vascular. British Nuclear Medicine Society Annual Meeting 18:310-311.

Book Chapters

Ng CS, Siefker-Radtke AO, Kamat A. Bladder Cancer and Upper Tracts. In: Oncologic Imaging. Elsevier, 311-333, 2012.
Patnana M, Gershenwald JE, W-J H, Ng CS. Melanoma. In: Oncologic Imaging. Elsevier, 633-652, 2012.
Iyer RB, Ng CS. Incidental extracolonic lesions: computed tomography. In: Cancer Imaging: Instrumentation and Applications. Elsevier Academic Press, 339-354, 2008.
Ng CS, Singh S, Truong MT. Critical care imaging in oncology patients. In: Acute Care of the Cancer Patient. Taylor & Francis, 847-871, 2005.
Ng CS, Lomas DJ, Dixon AK. Computed tomography and magnetic resonance imaging of the liver and pancreas. In: Oxford Textbook of Medicine. 4 ed. Oxford University Press, 674-678, 2003.

Letters to the Editor

Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C. Comparison of computed tomography methods for determining the fat content of the liver. AJR Am J Roentgenol 190: W168, 2008.
Ng C, Phongsathorn V, Mitchell S. Doctors should be trained in lifting patients. BMJ 315: 550-551, 1997.

Less

CV information above last modified February 13, 2026

Chaan S. Ng, MBBS, MD, PhD

About Dr. Chaan S. Ng

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Research Interests

Clinical Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Intramural Institutional Committee Activities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Professional Educational Materials

Other Articles

Abstracts

Book Chapters

Letters to the Editor

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop MD Anderson